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Abstract 
 
Ca2+ signal plays a fundamental role in modulating diverse cellular responses as 
muscle contraction, exocytosis, motility, fertilization, proliferation and apoptosis. Therefore, 
several proteins involved in this wide range of biological processes “manipulate” 
intracellular Ca2+ to (dis)regulate these events. To analyse Ca2+ homeostasis at the 
subcellular level, we employed the Ca2+-sensitive photoprotein aequorin, targeted to 
defined intracellular locations (organelles, such as mitochondria, endoplasmic reticulum, 
and cytoplasmic regions). 
Using this experimental approach, we investigated multiple effects on Ca2+ dynamics 
of three different proteins: i) the 66 KDa isoform of Shc protein (p66Shc) and its role on the 
alterations of mitochondrial Ca2+ homeostasis during oxidative stress. ii) The tumor 
suppressor protein Fhit and its role as sensitizer of the low-affinity Ca2+ transporters of 
mitochondria, and in turn potentiating the effect of apoptotic agents. iii) The proto-
oncogene Akt, a potent inhibitor of apoptosis, through the reduction of Ca2+ release from 
the ER during apoptotic stimulation.  
Taken together, these data remark the practical useful of Ca2+-dynamics investigation 
as a “reporter system” to understand different molecular mechanisms of different proteins 
and may provide ways to act on apoptotic cell death and its derangement in cancer. 
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Riassunto 
 
Il segnale Ca2+ gioca un ruolo fondamentale nel modulare diverse risposte cellulari 
come contrazione muscolare, esocitosi, mobilità cellulare, fertilità, proliferazione ed 
apoptosi. Perciò, diverse proteine implicate in questa ampia gamma di processi biologici 
“manipolano” la concentrazione di Ca2+ intracellulare per (dis)regolare questi processi. 
Per analizzare l’omeostasi del Ca2+ a livello sub-cellulare, il nostro laboratorio si 
avvale della tecnica dell’equorina, una foto-proteina sensibile al Ca2+ che può essere 
direzionata ai vari sub-compartimenti cellulari (organelli come mitocondri, reticolo 
endoplasmico e citoplasma). 
Usando questo approccio sperimentale, abbiamo studiato i diversi effetti riguardanti le 
dinamiche del Ca2+ di 3 proteine: i) la proteina p66Shc e il suo ruolo nell’alterazione 
dell’omeostasi del Ca2+ in condizioni di stress ossidativo. ii) l’oncosoppressore Fhit e la sua 
capacità nel sensibilizzare i trasportatori del Ca2+a bassa affinità e nel potenziare gli effetti 
di agenti apoptotici. iii) il proto-oncogene Akt, un potente inibitore del processo apoptotico, 
capace di inibire il rilascio di Ca2+ dal reticolo endoplasmico dopo stimolo apoptotico. 
Nel complesso questi dati sottolineano l’importanza dello studiare le dinamiche del 
segnale Ca2+, essendo questo un formidabile “sistema reporter” per meglio comprendere i 
meccanismi molecolari di proteine diverse. Inoltre, nello specifico, esso puo essere 
considerato un processo su cui poter agire per modificare il processo apoptotico e la sua 
disregolazione nel tumore. 
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1. Introduction 
 
1.1 The concept of Ca2+ as a cellular signal 
 
In the past two decades, our understanding of how extracellular signals are conveyed 
to eukaryotic cells via an increase in intracellular Ca2+ concentration has widely expanded. 
It is today common knowledge that a variety of extracellular stimuli (ranging from the 
binding of hormones, neurotransmitters, growth factors to phenomena such as cell-cell 
interactions), through diverse mechanisms (e.g. receptors that are themselves ion 
channels, or have an intrinsic enzymatic activity or are coupled to enzymatic effectors via 
G proteins) induce a rise in cytoplasmic Ca2+ concentration ([Ca2+]cyt) with defined 
amplitude and kinetics [1, 2]. 
In most eukaryotic cells, a large electrochemical gradient for Ca2+ exists across the 
plasma membrane. The transmembrane potential across the membrane is 70 to 90 mV. 
The interior of the cell is the more negative, yet the cytoplasmic concentration of Ca2+ 
([Ca2+]cyt) is less than one-ten thousandth of that in the extracellular milieu. There are also 
intracellular organelles, such as the endoplasmic reticulum (ER) and secretory granules, 
which contain one- to ten thousand fold greater concentrations of Ca2+ than the cytoplasm. 
Moreover, the technological advancements in probe design and imaging systems, by 
allowing the accurate measurement [Ca2+] at the single cell level, has revealed a marked 
asynchronicity in cell response and a high spatio-temporal complexity of the intracellular 
Ca2+ signal. We now know that the Ca2+ signal can be conveyed as repetitive [Ca2+]cyt 
spikes (commonly referred to as Ca2+ oscillations) [3], as well as localised [Ca2+]cyt 
increases that may either be confined or gradually propagate to the rest of the cell (“Ca2+ 
waves”) [4, 5].  
An extensive Ca2+-signalling toolkit is used to assemble signalling systems with very 
different spatial and temporal dynamics. Rapid highly localized Ca2+ spikes regulate fast 
responses, whereas slower responses are controlled by repetitive global Ca2+ transients or 
intracellular Ca2+ waves. The Ca2+ has a direct role in controlling the expression patterns of 
its signalling systems that are constantly being remodelled in both health and disease. 
During the on reaction, stimuli induce both the entry of external Ca2+ and the formation of 
second messengers that release internal Ca2+ that is stored within the endoplasmic 
reticulum or Golgi apparatus. Most of this calcium is bound to buffers, whereas a small 
proportion binds to the effectors that activate various cellular processes. During the off 
reactions, Ca2+ leaves the effectors and buffers and is removed from the cell by various 
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exchangers and pumps. The Na+/Ca2+ exchanger (NCX) and the plasma membrane Ca2+-
ATPase (PMCA) extrude Ca2+ to the outside, whereas the sarco/endoplasmic reticulum 
Ca2+-ATPase (SERCA) pumps Ca2+ back into the ER.  
Mitochondria also have an active function during the recovery process in that they 
sequester Ca2+ rapidly trough a uniporter, and release more slowly back into the cytosol to 
be dealt with by the SERCA and the PMCA. Cell survival is dependent on Ca2+ 
homeostasis, whereby the Ca2+ fluxes during the off reactions exactly match those during 
the on reaction. 
 
 
1.2 Generation (on reaction) and extinction (off reaction) of Ca2+ signalling 
 
Cells maintain a rigid control over the intracellular level of Ca2+, thus ensuring that the 
level is kept low during periods of inactivity. In order to use Ca2+ as a messenger, cells 
overcome this tight homeostatic control by using sophisticated mechanisms. An increase in 
the intracellular level of Ca2+ depends upon entry channels in the plasma membrane and 
release channels in the membranes of the internal stores, the endoplasmic reticulum (ER) 
or the Golgi apparatus. In first case, there are many different plasma membrane channels 
that control Ca2+ entry from the external medium in response to stimuli that include 
membrane depolarization, stretch, noxious stimuli, extracellular agonists. 
Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the 
plasma membrane. The cells use this external source of signal Ca2+ by activating various 
entry channels with widely different properties. We know the most about the voltage-
operated channels (VOCs), which are found in excitable cells and generate the rapid Ca2+ 
fluxes that control fast cellular process such as muscle contraction or exocytosis at 
synaptic endings. 
There are many other Ca2+-entry channels that open in response to different external 
signals, such as the receptor-operated channels (ROCs), for example the NMDA receptor 
that respond to glutamate. There also are second-messenger-opereted channels (SMOCs) 
that are controlled by internal messengers, such us the cyclic-nucleotide-gated channels 
that are found in sensory systems and the arachidonic-acid-sensitive channel. In addition 
to these more clearly defined channel-opening mechanisms, there are many other channel 
types that are sensitive to a diverse array of stimuli, such as the store-operated channels 
(SOCs) or G protein-operated-calcium channels (GOCCs). 
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The G protein-coupled receptors contains upwards of 1000 distinct members that 
mediate the vast majority of all responses to hormones, neurotransmitters, autocrine and 
paracrine factors. These integral membrane proteins have a conserved primary structure 
that contains seven stretches of 20-25 hydrophobic amino acid residues that span the 
plasma membrane. Hence, these important convertors of extracellular signals into 
intracellular signals are called seven transmembrane spanning domain receptors. Upon 
binding of agonist, GOCCs undergo a conformational change which then allows for 
productive coupling to heterotrimeric guanine regulatory proteins (G proteins). The active 
conformation of the agonist-occupied G protein-coupled receptor acts as a guanine 
nucleotide exchange factor for the heterotrimeric G protein and activates the G protein by 
promoting the dissociation of GDP and loading of GTP onto the G protein  subunit. In 
order to limit the magnitude and duration of the extracellular stimulus, the signalling 
cascade has to be dynamically regulated. In fact, most stimuli are short lived (milliseconds 
to minutes) as their response wanes over time even in the presence of saturating 
concentrations of agonist. This phenomenon is termed desensitization. Several different 
processes with varying time frames are responsible for desensitization. 
The release of Ca2+ from internal store is controlled by Ca2+ itself, or by an expanding 
group of  messengers, such as inositol–1,4,5–triphosphate (IP3), cyclic ADP ribose 
(cADPr), nicotinic acid adenine dinucleotide phosphate (NAADP) and sphingosine-1-
phosphate, that either stimulate or modulate the release channels on the internal stores. 
The most ubiquitous of the intracellular Ca2+ release mechanisms involves the 
phosphoinositide specific phospholipase C-derived second messenger (IP3), which acts by 
binding to a specific receptor (IP3R) on the endoplasmic reticulum. Distinct subtypes of the 
receptor exist, representing products of at least three distinct genes, and additional forms 
arise as a result of alternative splicing of mRNA. The interaction of IP3 with its receptor 
involves complex and poorly understood regulatory interactions among the receptor, IP3 
and Ca2+, the latter exerting influence from both the cytoplasmic and luminal aspects of the 
receptor. Ca2+ in the lumen of the ER appears to sensitize the receptor to IP3. On the 
cytoplasmic surface, low concentrations of Ca2+ sensitize the receptor, while higher 
concentrations are inhibitory. These actions may contribute to the "all-or-none" oscillatory 
behaviour of [Ca2+]cyt signals observed in some cell types.  
The other major type of intracellular Ca2+-mobilizing receptor is the ryanodine 
receptor (RYR). The ryanodine receptor family comprising three members: RYR1 found in 
skeletal muscle and certain neurones (e.g. Purkinje cells), RYR2 found in cardiac muscle, 
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brain and some other cells, and RYR3 found in smooth muscle, brain and other cells [6], 
[7]. In its most specialized setting, in skeletal muscle, the RYR is gated by a direct 
conformational interaction with a dihydropyridine receptor in the t-tubule membrane. This 
coupling allows for rapid release of stored Ca2+ when an action potential invades the t-
tubule system. However, the physiological ligand for the RYR is usually Ca2+ itself; 
because of this, it is considered to be a Calcium-Induced Calcium Release receptor-Ca2+ 
channel. Because Ca2+ can sensitize the IP3 receptor to IP3, the IP3 receptor also can 
exhibit a Calcium-Induced Calcium Release behaviour. However, some IP3 is always 
required for its action, while the ryanodine receptor can function as a "pure" Calcium-
Induced Calcium Release receptor. Although the RYR is thought to be regulated primarily 
by Calcium-Induced Calcium Release, there is also a small water-soluble molecule that 
can function as a regulatory ligand for at least some forms of the ryanodine receptor. 
Cyclic adenosine diphosphate ribose (cADPr) functions in a manner somewhat similar to 
IP3: it increases the probability of the ryanodine receptor channel opening by increasing its 
sensitivity to Ca2+. 
During the course of a typical Ca2+ transient, the generation of Ca2+ signalling is 
counteracted by the systems of  switching off of Ca2+ signalling, during which time various 
pumps and exchangers remove Ca2+ from the cytoplasm.      
The pumping mechanisms have important homeostatic functions in that they maintain 
the resting level of Ca2+ and ensure that the internal stores are kept loaded. Four different 
pumping mechanisms are responsible for the off reaction: the plasma-membrane Ca2+-
ATPase (PMCA), the Na+/Ca2+ exchanger (NCX), SERCA (sarco/endoplasmic reticulum 
Ca2+-ATPase) and the mitochondrial calcium uniporter (MCU). PMCA and SERCA pumps 
have lower transport rates but high affinities, therefore they can respond to modest 
elevations in Ca2+ levels and set basal Ca2+ levels. The NCX and mitochondrial uniporter 
have much greater transport rates, and can limit Ca2+ transient over a wider dynamic 
range. 
Ca2+-ATPases constitute a large family of proteins that fall into two distinct groups, the 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), and the plasma membrane Ca2+-
ATPase (PMCA). Most eukaryotic cells co-express, in a tissue-specific and differentiation 
stage-specific manner, one or more types of SERCA and PMCA pumps. 
The PMCA are calcium pumps of the plasma membrane, largely responsible for the 
regulated transport of Ca2+ between the intracellular and the extracellular milieu. Mammals 
have four genes encoding the proteins PMCA1 through PMCA4. Each gene transcript is 
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alternatively spliced to generate several variants. Their distribution is tissue- and cell-
specific and undergoes regulation during cell development and differentiation. Traditionally, 
these pumps have been considered to play a housekeeping role in controlling basal Ca2+ 
levels, but more recently, it became clear that the presence (and the co-expression) of 
different isoforms must be related to a more specialized function [8]. 
The only known mechanism for accumulation of Ca2+ by the endoplasmic reticulum is 
through the actions of SERCA pumps. SERCA are calcium pumps involved in the transport 
of calcium from the cytosol to various intracellular stores such as the sarcoplasmic 
reticulum (SR), the endoplasmic reticulum (ER) and calciosomes. It catalyses Ca2+ 
transport to the lumen of the SR or ER by an active process that requires adenosine 
triphosphate (ATP). Enzyme phosphorylation and ATP hydrolysis result in translocation of 
the two Ca2+ ions bound to the enzyme from a high affinity site to a low affinity site. The 
two calcium ions are then released into the lumen of the intracellular stores [9]. 
Three separate genes encode the SERCA family. The SERCA 1 gene is exclusively 
expressed in fast twitch skeletal muscle. Developmentally regulated alternative splicing of 
SERCA 1 results in an adult isoform (SERCA 1a) and a neonatal isoform (SERCA 1b) [10-
12]. The SERCA 2 gene is expressed in slow-twitch skeletal muscle, cardiac muscle, 
smooth muscle and non-muscle tissues. Tissue-dependant processing of the SERCA 2 
gene transcript yields four SERCA 2 messenger ribonucleic acids (mRNAs) (classes 1–4). 
Class 1 mRNA encodes the SERCA 2a isoform, found in cardiac, smooth and slow twitch 
skeletal muscles. Class 2, 3 and 4 mRNAs encode the SERCA 2b isoform, ubiquitously 
expressed at low levels in all cell types [13, 14]. A third isoform, SERCA 3, is less well 
documented, but like the SERCA 2 gene, shows widespread tissue distribution [15]. 
Phospholamban (cardiac muscle) and sarcolipin (skeletal muscle) regulate SERCA 
activity, current models of Ca2+-ATPase regulation by phospholamban depict 
unphosphorylated phospholamban as an inhibitor of the Ca2+-ATPase, the inhibition is 
exerted by association of the two proteins [16, 17]. 
Na+/Ca2+ exchangers cooperate with the PMCA pumps to export Ca2+ from the 
cytosol using the energy of the Na+ (K+) gradient across the plasma membrane [18, 19]. 
Two basic types of Na+/Ca2+ exchangers have been characterized. They differ in the 
nature and stoichiometry of the transported ions: the protein found in the plasma 
membranes of cardiac and a number of other cells (the prototype of the Na+/Ca2+ 
exchangers denominated NCX) exchanges three Na+ for one Ca2+ [20], whereas the 
protein originally found in the outer segment of retinal rods and cones and latter in other 
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cells as well (denominated NCKX) imports four Na+ ions in the cytosol in exchange for one 
Ca2+ and one K+ [21]. Thus, the exchanger functions electrogenically, using the energy 
potential stored in the transmembrane Na+ gradient to extrude the Ca2+ against its 
concentration gradient. The exchangers are expressed at high level in brain and a few 
other tissues, in particular skeletal muscles, where the presence of multiple isoforms 
underlines the critical role of the exchanger in the control of cytosolic Ca2+ concentration in 
neurons. A particular case is that of synaptic transmission, a process that demands that 
the cytosolic Ca2+ concentration is constantly re-adjusted and where the exchanger has a 
key role. 
Mitochondrial Ca2+ uptake plays a key role in the regulation of many cell functions, 
ranging from ATP production to cell death. However, the molecular mechanism underlying 
this phenomenon has not yet been completely explained, indeed, while the contribution of 
OMM Ca2+ channels (VDAC) has been well characterized, little is known about the so-
called mitochondrial Ca2+ uniporter (MCU). MCU is a highly selective ion channel located 
in the mitochondrial inner membrane, with a dissociation constant ≤ 2 nM over monovalent 
cations, reaching saturation only at supraphysiological [Ca2+]cyt. Ca2+ crosses the inner 
mitochondrial membrane through the MCU thanks to the considerable driving force 
represented by the negative transmembrane potential [22]. Studies performed on isolated 
mitochondria allowed the identification of some regulatory molecules acting on MCU, in 
particular the most effective inhibitors are the hexavalent cation Rutenium Red (RuR) and 
its related compound RuR360 [23], clonazepam and CGP37157 [24]. Another important 
regulator of MCU is Ca2+ itself. As demonstrated by Moreau and its group [25], in fact, 
MCU has a biphasic dependence on cytosolic Ca2+ concentration: [Ca2+]cyt increase can 
both activate or inactivate mitochondrial Ca2+ uptake. 
 
 
1.3 Mitochondrial Ca2+ signalling: a turning point controlling cell fate 
 
In the past years, mitochondria have been shown to be a critical checkpoint, capable 
of releasing structural components into the cytoplasm of cells doomed to die via apoptosis 
[26]. These proteins normally retained in the organelle (that include an important 
component of the respiratory chain, cytochrome c, as well as newly discovered proteins, 
such as AIF and Smac/Diablo) are released into the cytoplasm, where they activate 
effector caspases and drive cells to apoptotic cell death [27]. Interestingly, Ca2+ has been 
shown to play an important function in this process, thus representing a complex signal 
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within the organelle, which can be decoded into radically different biological consequences 
[28-31]. 
Indeed, work from various labs has revealed that the alteration of the Ca2+ signal reaching 
the mitochondria and/or the combined action of apoptotic agents or pathophysiological 
conditions (e.g., oxidative stress, Cadmium injury) can induce a profound alteration of 
organelle structure and function [32, 33]. Different effects have been described. Szalai et 
al. showed in hepatocytes that, upon treatment with sub-optimal doses of the lipid mediator 
of apoptosis ceramide, the repetitive spiking of cytosolic Ca2+ concentration ([Ca2+]cyt) 
rather than triggering the activation of matrix dehydrogenases (and thus the stimulation of 
aerobic metabolism), causes opening of mitochondrial permeability transition pore (MPTP, 
the channel that allows the release in the cytosol of intermembrane-residing apoptotic 
factors) mitochondrial swelling and the release of cytochrome c [34]. Thus, a mechanism of 
coincidence detection of physiological agonists and apoptotic stimuli allows the specific 
induction of the apoptotic program (with mitochondria acting as the site where this 
differential decoding is operated). Subsequently, we have shown that in HeLa cells, 
ceramide directly causes the release of Ca2+ from the ER, and Ca2+ loading in 
mitochondria possibly in combination with a direct activity of the lipid mediator causes the 
morphological alteration of the organelle (fragmentation, swelling) and the ensuing release 
of cytochrome c and other caspase cofactors [33]. 
In all cases, the amount of Ca2+ released from the ER and the ability of mitochondria to 
accumulate it appear to play a critical role. In fact, a decrease of ER Ca2+ content protects 
cells from apoptotic cell death [35]; conversely, amplification of Ca2+ signals has a 
proapoptotic effect. In this respect, both in neurons and in hepatic cells it was observed 
that apoptotic signals (staurosporin in the former case, the proapoptotic X protein of 
Hepatitis B virus in the latter) cause the activation of caspase 3, with ensuing cleavage of 
the plasma membrane Ca2+ ATPase (that contain a consensus for caspase cleavage in its 
sequence) [36, 37]. Thus, the mechanism that allows the termination of the agonist 
induced Ca2+ signals is impaired, and [Ca2+]cyt rises are enhanced and prolonged. This 
causes mitochondrial Ca2+ overload and the apoptotic morphological and functional 
alterations of the organelles [31]. 
Therefore, is a general agreement in the literature that the increased energy demand 
required for carrying out different processes, such as muscle contraction, exocytosis, 
motility, fertilization, proliferation and gene expression, is met, in part, from the 
accumulation of some of the released Ca2+ by the mitochondria with the resulting Ca2+-
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dependent activation of key intramitochondrial enzymes linked to ATP production [38, 39]. 
The efficiency of this process is greatly enhanced by placement of ER and mitochondrial 
membranes in close proximity [40]. Thus the physiological release of Ca2+ through IP3Rs 
serves important signaling and “housekeeping” roles in maintaining normal function during 
agonist-mediated cell activation. However, in the presence of an apoptotic stimulus, the 
IP3R-mediated Ca2+ release can activate apoptotic pathways by inducing the release from 
mitochondria of a number of pro-apoptotic factors including cytochrome c. 
The present thesis is focused on studying the signal transduction pathways in living 
cells with particular emphasis on calcium signalling. In these studies I used a well 
established technique for measuring Ca2+ in subcellular compartments, that is based on 
the recombinant expression of the Ca2+-sensitive photoprotein aequorin, modified in order 
to include specific targeting sequences. This approach provides a formidable “read-out 
system” to understand how different proteins “manipulate” intracellular Ca2+ homeostasis in 
order to exert their biological functions. 
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2. Tools 
 
The wide expansion of molecular biology techniques, with the possibility of 
modifying and expressing exogenous cDNAs in virtually all cell types, has been 
responsible for the growing success in the use of protein probes in cell biology. Two 
groups of reporter proteins are currently employed, derived from the wide variety of 
bioluminescent organisms: the chemiluminescent proteins (e.g. the different types of 
aequorin), and the fluorescent proteins (e.g. the green fluorescent protein, GFP). 
The Ca2+-sensitive photoprotein aequorin was targeted to defined intracellular 
locations (organelles, such as mitochondria, endo- and sarcoplasmic reticulum, Golgi 
apparatus and nucleus, and cytoplasmic regions, such as the bulk cytosol and the 
subplasmalemmal rim) and used to analyse Ca2+ homeostasis at the subcellular level. 
 
 
2.1 Aequorin 
 
Aequorin is a Ca2+ sensitive photoprotein of a coelenterate, isolated from the 
jellyfish Aequorea Victoria. The protein is composed of a 21 kDa apoprotein and a 
hydrophobic prosthetic group, coelenterazine (MW~400 Da). The 2 components must be 
associated for the Ca2+-triggered light emission to occur. The holoprotein possesses 3 high 
affinity Ca2+ binding sites (homologous to the sites present in other Ca2+ binding proteins, 
such as calmodulin). Upon binding of Ca2+ ions, the coelenterazine is oxidized to 
coelenteramide, with a concomitant release of carbon dioxide and emission of light; this is 
an irreversible reaction where one photon is emitted. 
 
 
 
 
 
 
Fig. 1: The aequorin reaction: Aequorin is composed of an apoprotein and a prosthetic group, 
coelenterazine, and its polypeptide sequence includes three high affinity Ca2+-binding sites. Ca2+ binding 
causes the rupture of the covalent link between the apoprotein and the prosthetic group, a reaction 
associated with the emission of one photon. 
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Although this reaction is irreversible, in vitro an active aequorin can be obtained by 
incubating the apoprotein with coelenterazine in the presence of oxygen and 2-
mercaptoethanol. Reconstitution of an active aequorin (expressed recombinantly) can be 
obtained also in living cells by simple addition of coelenterazine to the medium. 
Coelenterazine is highly hydrophobic and has been shown to permeate cell membranes of 
various cell types, ranging from the slime mold Dictyostelium discoideum to mammalian 
cells and plants [41]. 
The possibility of using aequorin as a calcium indicator is based on the existence of 
a well-characterized relationship between the rate of photon emission and the free Ca2+ 
concentration. The rate of this reaction depends on the Ca2+ concentration ([Ca2+]) to 
which the photoprotein is exposed. In particular, at [Ca2+] between 10-7 and 10-5 M (the 
concentration normally occurring in the cytoplasm of living cells), there is a direct 
relationship between [Ca2+] and the fractional rate of consumption of the photoprotein. 
 
 
Fig. 2: Relationship between the free Ca2+ concentration and the rate of aequorin photon emission. 
The fractional rate of aequorin consumption is expressed as the ratio between the emission of light at defined 
[Ca2+] (L) and the maximal rate of the light emission at saturating [Ca2+] (L max). 
 
Figure 2 shows the Ca2+ response curve of aequorin, at physiological conditions of 
pH, temperature, and ionic strength. It is apparent that the fractional rate of aequorin 
consumption expressed as the ratio between the emission of light at a defined Ca2+ 
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concentration (L) and the maximal rate of the light emission at saturating [Ca2+] (Lmax) is 
proportional to the 2nd-3rd power of [Ca2+]. Indeed, if all the light emitted by the 
photoprotein throughout an experiment, as well as that discharged at the end are collected 
it is possible to estimate Lmax and then calculate back the [Ca2+] to which the photoprotein 
is exposed in every moment. 
Although aequorin luminescence is not influenced either by K+ or Mg2+ (which are 
the most abundant cations in the intracellular environment and thus the most likely source 
of interference in physiological experiments) both ions are competitive inhibitors of Ca2+ 
activated luminescence. Aequorin photon emission can be also triggered by Sr2+ but its 
affinity is about 100 fold lower than that of Ca2+, while lanthanides have high affinity for the 
photoprotein (e.g. are a potential source of artifacts in experiments where they are used to 
block Ca2+ channels). pH was also shown to affect aequorin luminescence but at values 
below 7. 
  In fact all experiments of this thesis with aequorin need to be done in well-controlled 
conditions of pH and ionic concentrations, notably of Mg2+. 
 
2.1.1 Recombinant Aequorin 
 
In the past, was widely employed to measure Ca2+ concentration in living cells, in 
fact the purified protein was widely used to monitor cytoplasmic [Ca2+] changes in 
invertebrate muscle cells after microinjection. However, due to the time-consuming and 
traumatic procedure of microinjection, the role of aequorin in the study of Ca2+ 
homeostasis remained confined to a limited number of cells (giant cells) susceptible to 
microinjection. 
The cloning of aequorin cDNA [42] and the explosive development of molecular 
biology offered new possibilities in the use of aequorin, as microinjection has been 
replaced by the simpler technique of cDNA transfection, opening the way to recombinant 
expression and thus has largely expanded the applications of this tool for investigating 
Ca2+ handling in living cells. As a polypeptide, aequorin allows the endogenous production 
of the photoprotein in cell systems as diverse as bacteria, yeast, plants and mammalian 
cells. 
In particular, recombinant aequorin can be expressed not only in the cytoplasm, but 
also in specific cellular locations by including specific targeting sequencing in the 
engineered cDNAs.  
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Extensive manipulations of the N-terminal of aequorin have been shown not to alter 
the chemiluminescence properties of the photoprotein and its Ca2+ affinity. On the other 
hand, even marginal alterations of the C-terminal either abolish luminescence altogether or 
drastically increase Ca2+ independent photon emission [43]. As demonstrated by Watkins 
and Campbell [44], the C-terminal proline residue of aequorin is essential for the long-term 
stability of the bound coelenterazine. For these reasons, all targeted aequorins 
synthesized in our laboratory include modifications of the photoprotein N-terminal. Three 
targeting strategies have been adopted:  
1. Inclusion of a minimal targeting signal sequence to the photoprotein cDNA.  
2. Fusion of the cDNA encoding aequorin to that of a resident protein of the compartments 
of interest.  
3. Addition to the aequorin cDNA of sequences that code for polypeptides that bind to 
endogenous proteins. 
 
2.1.2 Chimeric Aequorin cDNAs (Fig. 3) 
 
Below I briefly describe the constructs that were present in our laboratory and that I 
used for the thesis. 
 Aequorin targeted to cytoplasm (cytAEQ) 
An unmodified aequorin cDNA encodes a protein that, in mammalian cells is located 
in the cytoplasm and, given its small size, also diffuses into the nucleus. An alternative 
construct was also available that is located on the outer surface of the ER and of the Golgi 
apparatus. This construct was intended to drive the localization of aequorin to the inner 
surface of the plasma membrane given that it derives from the fusion of the aequorin cDNA 
with that encoding a truncated metabotropic glutamate receptor (mgluR1). The encoded 
chimeric protein, however, remains trapped on the surface of the ER and Golgi apparatus, 
with the aequorin polypeptide facing the cytoplasmic surface of these organelles. The 
cytoplasmic signal revealed by this chimeric aequorin is indistinguishable from that of a 
cytoplasmic aequorin, but it has the advantage of being membrane bound and excluded 
from the nucleus. 
 Aequorin targeted to mitochondria (mtAEQ) 
The mtAEQ probe has been successfully employed to measure the [Ca2+] of the 
mitochondrial matrix of various cell types. This construct includes the targeting 
presequence of subunit VIII of human cytochrome c oxidase fused to the aequorin cDNA 
[45]. 
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 Aequorin targeted to Endoplasmic reticulum (erAEQ) 
The erAEQ includes the leader (L), the VDJ and Ch1 domains of an Ig2b heavy 
chain fused at the N-terminus of aequorin. Retention in the ER depends on the presence of 
the Ch1 domain that is known to interact with high affinity with the luminal ER protein BiP 
[46].  
 
 
Fig. 3: Schematic representation of aequorin chimeras. 
 
2.1.3 Luminescence detection 
 
The aequorin detection system is derived from that described by Cobbold and Lee 
[47] and is based on the use of a low noise photomultiplier placed in close proximity (2-3 
mm) of aequorin expressing cells. The cell chamber, which is on the top of a hollow 
cylinder, is adapted to fit 13-mm diameter coverslip. The volume of the perfusing chamber 
is kept to a minimum (about 200 µl). The chamber is sealed on the top with a coverslip, 
held in place with a thin layer of silicon. Cells are continuously perfused via a peristaltic 
pump with medium thermostated via a water jacket at 37°C. The photomultiplier (EMI 9789 
with amplifier-discriminator) is kept in a dark box and cooled at 4°C. During manipulations 
on the cell chamber, the photomultiplier is protected from light by a shutter. During 
aequorin experiments, the shutter is opened and the chamber with cells is placed in close 
proximity of the photomultiplier. The output of the amplifier-discriminator is captured by an 
EMIC600 photon-counting board in an IBM compatible microcomputer and stored for 
further analysis. In order to calibrate the crude luminescent signal in terms of [Ca2+] an 
algorithm has been developed that takes into account the instant rate of photon emission 
and the total number of photons that can be emitted by the aequorin of the sample13. In 
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order to obtain the latter parameter, at the end of each experiment the cells are lysed by 
perfusing them with a hyposmotic medium containing 10 mM CaCl2 and a detergent (100 
µM digitonin or 0,1% Triton X-100) in order to discharge all the aequorin that was not 
consumed during the experiment. 
A schematic representation of custom-made luminometer used in my laboratory is 
shown in figure 4. 
 
Fig. 4: Schematic representation of a custom-built luminometer. Cells loaded with functional aequorin 
probe are incubated in a perfusion chamber, at 37°C, in close proximity to a photon-counting tube. The 
complete assemblage is kept at 4°C, in the dark, to minimize extraneous signals. Acquisition of the data and 
subsequent calculations to transform light emission into [Ca2+] are performed by a dedicated computer 
algorithm. 
 
2.1.4 Advantages and disadvantages of aequorin 
 
In this section I will focus on the main characteristics that make aequorin such a 
flexible and powerful intracellular calcium sensor. 
 Advantages: 
1) Selective intracellular distribution. Whereas recombinantly expressed wild-type aequorin 
is exclusively cytosolic, the intracellular fate of the photoprotein can be modified by adding 
specific targeting sequences.  
2) High signal-to-noise ratio. Due to the low luminescence background of cells and the 
steepness of the Ca2+ response curve of aequorin, minor variations in the amplitude of the 
agonist-induced [Ca2+] changes can be easily appreciated with aequorin.  
3) Low Ca2+ buffering effect. Although the binding of Ca2+ by aequorin may, in principle, 
affect intracellular Ca2+ homeostasis, this undesired effect is less relevant than with 
4°C
37°C
water circuit
Photomultiplier
Peristaltic
pump for
perfusion
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fluorescent indicators. In fact, thank to the excellent signal to noise ratio, aequorin is 
loaded at a concentration which is 2-3 orders of magnitude lower than dyes, i.e. usually 
from <0.1 µM (for the recombinantly expressed photoprotein) to ~1 µM (in the case of 
microinjection of the purified photoprotein for single cell studies).  
4) Wide dynamic range. It is clearly evident from Fig. 2 that aequorin can accurately 
measure [Ca2+] ranging from 0.5 µM to 10 µM, i.e. reaching concentrations at which most 
fluorescent indicators are saturated. Indeed, thank to these properties and to the low 
buffering effect, it is possible to estimate the large [Ca2+]c rises which occur, for example, in 
neurons [48]. Moreover, by introducing point-mutations in the Ca2+-binding sites [49], using 
surrogate cations, such as Sr2+, and/or modified prosthetic groups, the sensitivity of the 
recombinant photoprotein can be further reduced, and thus the [Ca2+] can be monitored 
also in intracellular compartments endowed with high [Ca2+] (e.g. the lumen of the ER).  
5) Possibility of co-expression with proteins of interest. A powerful approach for 
investigating the role, and the properties, of the various molecular components of the Ca2+ 
signalling apparatus is either the overexpression of the heterologous protein, followed by 
the study of the molecularly modified cell. This can be accomplished in two ways, either by 
generating stably transfected cell clones, or by transiently expressing the protein of interest 
in a cell type. 
 Disadvantages: 
1) Overestimation of the average rise in cells (or compartments) with dishomogeneous 
behaviour. A disadvantages of the steepness of the Ca2+ response curve of aequorin is 
that, if the increase of the [Ca2+] is not homogeneous, the average estimate will be based 
towards the highest values. Indeed, by using targeted aequorin to monitor 
subplasmalemmal Ca2+ concentration, we measured a mean resting [Ca2+] of 1-2 µM, 
which most likely does not reflect the real average [Ca2+]pm value, but, rather, the 
contribution of microdomains in the proximity of flickering Ca2+ channels [50]. 
2) Low light emission. In distinction to the fluorescent dyes (where up to 104 photons can 
be emitted by a single molecule, before photobleaching occurs), only 1 photon can be 
emitted by an aequorin molecule. Moreover, the principle of the use of aequorin for Ca2+ 
measurements is that only a small fraction of the total pool (varying, in a typical 
physiological experiment, from 10-7 to 10-2) emits its photon every second. This is not a 
major limitation in population studies, as averaging over 103-104 cells. Conversely, single 
cell imaging requires very high expression and special apparatuses [51] and it is endowed 
with lower spatial and temporal resolution than that obtained with fluorescent indicators.  
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2.2 Green Fluorescent Protein (GFP) 
 
In recent years, two decisive methodological advances have greatly improved 
optical microscopy and allowed to follow biological processes in living cells: the 
improvement of the instrumentation (with the development of confocal microscopes and of 
mathematical methods for image analysis) and the discovery of the "green fluorescent 
protein" (GFP), a protein derived from a jellyfish that can be utilized as a highly efficient 
intracellular probe in fluorescence microscopy. It is thus now possible to follow directly in 
intact, living cells cellular events of major biomedical relevance, such as the movement of 
proteins (including their mutated variants in genetic diseases) or intracellular organelle 
distribution. The possibility of directly identifying intracellular organelles in living cells has a 
major relevance in these cell biology studies. Indeed, key events, such as organelle 
distribution and dynamics, can be monitored in a variety of physiological phenomena (e.g. 
localized Ca2+ rises), and also the intracellular location (and the relative relations between 
the different organelle) can be unambiguously identified. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: The chemical structure of the chromophore in Aequorea GFP. Structural formula of GFP.       
GFP has a cylindrical fold. Two protomers associate together to form a dimer in the crystal and also in 
solution at low ionic strengths, <100 mM. Dimerization has an effect on the excitation spectra and energy 
transfer of GFP. The dimer is involved in physiological interactions with aequorin for efficient energy transfer. 
The structure is comprised of two regular beta-barrels. 
 
Green fluorescent protein, GFP, is in nature the legitimate partner of aequorin. 
Indeed, it is produced by the same jellyfish (Aequorea victoria) and packed in close 
association to the photoprotein, acting as a natural fluorophore that absorbs the blue light 
emitted by the photoprotein and re-emits photons of a longer wavelength (thus accounting 
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for its own name and for the greenish hue of the jellyfish luminescence) [41, 52, 53]. In 
research applications, GFP retains its fluorescence properties, and thus can be added to 
the long list of probes of the cell biologist’s toolbox [54]. Some of its unique properties 
account for its explosive success, and has made it, in relatively few years (the first report of 
GFP expression in heterologous systems dates back to 1994) [55], a powerful and 
versatile tool for investigating virtually all fields of cell biology (ranging from the study of 
gene expression to protein sorting, organelle structure, measurement of physiological 
parameters in living cells) [56, 57].  
The main reason for the success of GFP is its own nature: the fluorescent moiety is 
a gene product (with no need for cofactors) that is open to molecular engineering and 
transient or stable expression in virtually every cell type. Moreover, its mutagenesis has 
allowed the adaptation of its fluorescent properties to different experimental needs (for a 
detailed description see reviews [54, 58]).  
GFP mutants can be grouped in two major classes: the first are the “optimising” mutations, 
i.e. those that increase light emission by either altering the intrinsic properties of the 
fluorescent protein [59, 60] or increasing its production in mammalian cells [61]. The latter 
are the so called “humanised” versions of the cDNA, in which silent mutations are 
introduced in order to convert some of the codons into the most common and efficient for 
translation in mammalian cells. 
As to the modification of GFP properties, mutations have been described that alter 
the stability of the protein and/or the quantum efficiency upon illumination with visible light 
(native GFP has a bimodal excitation peak, larger with UV than with blue light, while all 
currently employed green variants of GFP are best excited with blue light, thus minimising 
cytotoxicity and photobleaching). Among these mutations, the most useful appears to be 
the substitution of Ser65 into Thr (S65T), which causes the chromophore to be entirely in 
the anionic form: thus, when compared to wild-type GFP the quantum efficiency upon 
excitation with blue light is 6-fold increased, the rate of fluorophore formation is 4-fold 
faster and photobleaching is markedly reduced. The second class is represented by GFPs 
emitting light of a wavelength that can be clearly distinguished from the green colour of 
native GFP. This class includes some popular mutants commonly referred to as blue 
(Y66H, Y145F), cyan (Y66W) and yellow (T203Y) GFPs. 
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Fig. 6: Excitation (A) and emission (B) spectra of different GFP mutants. 
 
Another green fluorescent protein, found in the sea pansy Renilla, has been 
biochemically characterised [62], while the cDNA has not been isolated yet. Although the 
chromophore of Renilla is similar to that of Aequorea, some of their biochemical properties 
differ. Renilla GFP has a much higher extinction coefficient, is an obligate dimer and is 
more resistant to pH-induced conformational changes, which could make it useful for some 
cell physiology studies.  
Nowadays the most frequent application of the GFPs is to use them as a tag. In fact, 
fusing in frame the GFP cDNA to a cDNA coding for a protein of interest, it is possible to 
examine the function and fate of the resulting chimera in living cells. Moreover, chimeras 
with different spectral properties can be employed for visualising simultaneously two 
proteins of interest (e.g. two isoforms of a signalling molecule) or the morphology and 
spatial relationship between two intracellular compartments. The GFPs can also be used 
as a tool for analysing transfection efficiency or as sensors for physiological parameters. 
This approach stems from an interesting phenomenon, called fluorescence resonance 
energy transfer (FRET), occurring between two GFPs with different colours. FRET may 
occur only if the fluorescence emission spectrum of the “donor” GFP overlaps with the 
excitation spectrum of the “acceptor” GFP and if the two fluorophores are located within 
few nanometers in a favourable orientation. 
 
As for aequorin I briefly describe the GFP constructs that were present in our 
laboratory and that I used for the thesis: 
 mitochondrial GFP probe: the previously employed mitochondrial presequence 
derived from subunit VIII of cytochrome c oxidase (encoding the 25 aa-long presequence 
and 6 aa of the mature polypeptide) to construct a mitochondrially targeted aequorin 
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chimera [45] was fused in frame with the GFP, in order to construct mitochondrially-
targeted GFP (mtGFP) [63]. When expressed in mammalian cells, the chimeras show a 
typical mitochondrial distribution. 
 
                   A 
 
                                            
 
                                           B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: The mitochondria-targeted GFP construct. The mitochondrial presequence of COX VIII protein 
was fused in frame with GFP at N-terminus (A). As aspected, this chimera shows a typical mitochondrial 
staining (B). 
 
 
2.3 Experimental set-up: collecting and analysing the GFP images 
 
The fluorophore of GFP is formed by the cyclization of three amino-acid residues of 
the primary sequence. This process directly follows, with few constraints (a relatively brief 
time lag), the synthesis of the protein, and thus GFP proved brightly fluorescent when 
expressed in a wide variety of cell types (mammalian cells, plants, fungi, bacteria, etc.) and 
intracellular locations (cytoplasm and virtually every organelle). Thus, also in our 
experiments the various GFP chimeras are transfected with the appropriate procedure 
(calcium phosphate, liposomes or particle gun, depending on the cell type), and directly 
visualised in living cells after allowing sufficient time for expression and chromophore 
formation (usually 24-36 hours). For this purpose, the coverslip with the transfected cells is 
fitted at the base of a thermostatted chamber, which is placed on the microscope stage. 
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Fig. 8: Microscope setting. A digital imaging system, built on an epifluorescence microscope, is equipped 
with filter-wheels placed on the excitation and emission light paths, a piezoelectric motor and a CCD camera. 
The system is operated by a software that also permits to analyse and computationally deblur the images. 
 
Our microscope set up is presented in figure 8. In brief, a traditional wide-field, 
epifluorescence microscope is equipped with filter-wheels located both in the incoming and 
in the out-coming light paths (thus allowing to rapidly alternate excitation and/or emission 
wavelength) and a piezoelectric transducer (or motor drive) for rapid focussing in the z 
plane. The fluorescence image is collected by a back-illuminated and cooled (-40°C), 
charge coupled device (CCD) camera having high quantum efficiency (>70% at 500nm) 
and low noise (<10e- RMS at 1MHz) characteristics, and the image is stored as a digital file 
using the Metamorph/Metafluor program (Universal Imaging). This allows the direct 
monitoring of fluorescence intensity, important for some applications (e.g. the monitoring of 
FRET, or the pH measurements using the pH-sensitive GFP mutants, a topic that for 
reasons of brevity will not be discussed in this thesis).  
A high-resolution, 3-D reconstruction of the distribution of a GFP chimera can be 
obtained with the technique of digital image restoration, also called deconvolution or 
deblurring. [64]. 
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In situations where there may be significant intracellular motion of the GFP chimera, 
two approaches can be used to decrease the time for image acquisition.  The area of the 
cell (i.e. the number of pixels in each optical section) imaged can be reduced, thus 
decreasing the time to transfer the image data to computer storage. A high-resolution 
image restoration of a limited volume of a cell has been obtained using a few as 5 to 7 
optical sections [65], minimising the total acquisition time. 
A high-speed version of this microscopy has been developed [66] that can acquire 
an entire through-focus image series of a GFP labelled cell in less than 1 second.  This 
microscope system can be used to follow spatial and temporal intracellular dynamics (e.g. 
motor-protein based transport, signal transduction) too rapid for conventional fluorescence 
microscopy [66]. Conversely, if only the time course rather than the 3-D distribution of a 
fast process (e.g. Ca2+ signalling) needs to be assessed, single fluorescent images of the 
microscope field of interest can be acquired every 10-20 ms with no further image 
processing [67]. 
 Finally, the filter-wheels allow the alternate imaging of two different fluorophores at 
different excitation and emission wavelengths, and thus the simultaneous visualisation of 
two different proteins of interest in the same cell, or the measurement of donor and 
acceptor fluorescence in FRET applications. When compared to laser scanning confocal 
microscopy, digital imaging is characterised by higher flexibility in the selection of 
excitation wavelengths, lower illumination intensity (thus reducing photobleaching and 
photodamage) and lower cost. Conversely, its disadvantages are the need for time-
consuming off-line image processing and the unsuitability for the analysis of thick 
specimen (e. g. tissue slices). 
 
 
2.4 Luciferase 
 
Firefly luciferase was cloned in the late 1980s [68], and versions of the gene, 
optimised for thermostability and expression in mammalian cells, were generated. The 
enzyme uses an oxidisable substrate, termed luciferin, which is converted to an AMP 
adduct before final oxidation with molecular oxidation and the release of a photon of light 
(Fig. 9). 
cDNA encoding luciferase can readily be introduced into most mammalian (and 
other) cell types by conventional transfection techniques. Whilst originally also intended for 
detection of the total luciferase amount in cell homogenates, luciferase light output can 
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also be readily measured from living cells, after the addition of the (reasonably cell-
permeant) cofactor, luciferin. Under most conditions, O2, and cofactors other than ATP, are 
not limiting. Further, it can be calculated that the contribution of ATP consumption by 
luciferase represents only a tiny fraction of total cellular ATP turnover (<0.1 %, even at 
relatively high levels of luciferase expression, e.g. 1 x 106 molecules/cell) and thus non-
perturbing for normal cellular ATP homeostasis.  
 
 
 
 
 
 
 
Fig. 9: The ATP-dependent luminescence reaction of Luciferase 
 
The technology to the detection of changes in free intracellular ATP concentration 
require constantly high levels of luciferase expressed from strong viral promoters (e.g. the 
cytomegalovirus immediate early gene promoter, CMV-IE), so that small fluctuations in 
free ATP concentration can be monitored in cell populations, by detection of luciferase 
luminescence is possible with the photon-counting tube apparatus, as described above for 
the detection of aequorin luminescence. 
Luciferase displays a Km for ATP close to 1 mM when assayed in cell homogenates 
under approximate in vivo conditions of pH and physiological ionic strength [69] (compared 
to the low micromolar range under optimal in vitro conditions). 
Confirming these values in living cells is complicated due to the distinct kinetics of 
the enzyme in the living cell (“glow” versus “flash” kinetics”). Although the basis for this 
difference is not fully understood, it may reflect a lack of the accumulation of inhibitory end 
product (oxyluciferin) in the cell, or a decreased sensitivity to this (or another inhibitor) 
mediated by other cellular cofactors (notably CoA). Whatever the mechanism, this makes 
monitoring [ATP] constantly in the living cell relatively straightforward, given sensitive 
photon detection equipment. 
In order to measure [ATP] exclusively into the mitochondrial compartment ([ATP]mt), 
our groups generated a mitochondrial-targeted luciferase, using the same strategies 
employed for creation of mtAEQ and mtGFP chimera (Fig. 10) [70]. Moreover, this paper 
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shown how stimulation with agonists evoking cytosolic and mitochondrial Ca2+ signals 
caused increases in [ATP]mt and [ATP]cyt [70]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Map and correct localization of mtLUC construct. A) Schematic map of the chimeric 
mitochondrial luciferase. Lines and bars indicate the noncoding and coding regions [gray, cytochrome c 
oxidase subunit VIII (COX8); black, HA1; white, luciferase], respectively. (B) Immunofluorescence image of 
HeLa cells transiently transfected with mtLuc and stained with the anti-HA1 mAb (figure from [70]). 
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3. Protein Kinase C β and Prolyl Isomerase Pin1 Regulate Mitochondrial 
Effects of the Life-Span Determinant p66Shc 
 
3.1 Introduction 
 
Many agents which induce apoptosis are either oxidants or stimulators of cellular 
oxidative metabolism. Conversely, many inhibitors of apoptosis have antioxidant activities 
or enhance cellular antioxidant defences. Mammalian cells exist in a state of oxidative 
siege in which survival requires an appropriate balance of oxidants and antioxidants, 
suggesting that eukaryotic cells may benefit from this perilous existence by invoking 
oxidative stress as a common mediator of apoptosis. 
Apoptosis, the process that allows multicellular organisms to eliminate unnecessary, 
dangerous or damaged cells without evoking inflammation or tissue damage, occurs in 
both physiological and pathological contexts. Specific biochemical steps in the apoptotic 
pathway are inhibited by viruses and in tumors. On the other hand, excess apoptosis in 
non-proliferating cells has been proposed to be the basis of a number of degenerative 
disorders, as well as in progressive loss of organ function during ageing. The 
understanding of the control mechanisms of apoptosis is thus a major goal for the 
understanding of these pathophysiological events, and the development of novel 
therapeutic approaches. 
Recently the mitochondrion has emerged as a key decoding station of the apoptotic 
process. Indeed, a large body of experimental evidence has unambiguously revealed that 
mitochondria trigger cell death, in addition to the well-established function of producing 
most of cellular ATP. Various apoptotic stimuli cause the release of specific mitochondrial 
proteins into the cytoplasm (including an essential component of the electron transfer 
chain, cytochrome c). Their assembly with cytosolic proteins forms a complex (the 
“apoptosome”), that recruits and activates effector caspases, which in turn trigger apoptotic 
death. The molecular mechanism of this release is still controversial, but may require the 
activity of a large-conductance channel, known as the permeability transition pore, PTP. Its 
opening induces the swelling of mitochondria, and this large-scale alteration of organelle 
morphology (with perturbation or rupture of the outer membrane) may allow the release of 
pro-apoptotic components into the cytosol. 
There is no doubt that cell death belongs to the numerous cell functions on which Ca2+ 
exerts a complex regulatory role. As to the site of action of the “apoptotic” Ca2+ signal, 
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mitochondria again emerge as a critical site. Indeed, treatment with apoptotic stimuli, such 
as ceramide, causes a release of Ca2+ from the ER and induces dramatic changes of 
mitochondrial morphology [33]. If Ca2+ changes are prevented (e.g. by loading an 
intracellular Ca2+ buffer), mitochondrial morphology is preserved and the cells are protected 
from apoptosis. Much remains to be understood on the additional signals that converge on 
mitochondria and switch their function into apoptotic inducers. As much as Ca2+ appears to 
be involved, there is no doubt that coincident detection of other “pro-apoptotic” conditions 
needs to occur. Indeed, mitochondria can handle in physiological conditions large Ca2+ 
loads (e.g. in cardiac myocytes significant amounts of Ca2+ are accumulated at every 
heartbeat), with no deleterious effects. As to the additional “apoptotic signal”, the most 
important is considered to be oxidative stress. However, on this topic the information is 
very scant, as its real significance in apoptosis and the mechanism of action are still largely 
unknown. 
In 1999, the group of Pelicci and co-workers published a paper that became a crucial 
point in studies on the oxidative stress [71]. They proposed that mammalian life span can 
be controlled by p66Shc protein due to regulation of cellular response to oxidative stress. 
Ablation of the p66Shc gene causes life-span prolongation with no pathological 
consequence. In fact, mice lacking p66Shc gene had enhanced resistance to oxidative 
stress induced by paraquat (a potent inducer of oxidative stress in vivo).  
 
3.1.1 p66Shc, an adaptor protein 
 
The p66Shc protein is an alternatively spliced isoform of the growth factor adapter. 
Recently, three proteins from ShcA family have been identified (p66Shc, p52Shc and 
p46Shc). Each of them contains three functionally identical domains: the carboxy terminal 
Src homology 2 (SH2) domain, the central proline-rich domain (CH1), and the N-terminal 
phosphotyrosine-binding domain (PTB). PTB domain can bind to phospholipids and 
phosphotyrosine of the other proteins (Fig. 11). 
 
 
 
 
 
 
 
Fig. 11: Structure of Shc proteins. 
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P66Shc protein differs from p46Shc and p52Shc by the presence of an additional N-
terminal proline-rich domain (CH2) with the serine phosphorylation site, Ser36. 
Phosphorylation of this residue plays an important role in the cellular response to the 
oxidative stress. Recently, it has been demonstrated that, in response to UV or H2O2 
treatment, p66Shc is phosphorylated mainly at serine 36 in the N-terminal CH2 domain [71]. 
Also a p66Shc transfection with mutated Ser36 failed to restore apoptosis sensitivity in 
p66Shc lacking cells, what supports the importance of Ser36 in regulation of apoptosis. 
The SH2 domain of Shc is important for certain receptor interactions, such as 
epidermal growth factor (EGF) receptor. Interaction between the SH2 domain and EGF 
receptor plays an important role in phosphorylation of tyrosines in the CH1 domain of 
p52Shc and p46Shc [72]. Tyrosine phosphorylation enables them to bind to the adaptor 
Grb2 protein–activator of Ras protein. Also p66Shc can be tyrosine phosphorylated, but 
there are no evidences about its ability to activate the Ras signalling pathway.  
Further studies of the mechanism of lifespan-promoting activity of p66Shc 
deficiency, have suggested not only a role in ROS metabolism, but also in apoptosis. 
Steady-state ROS and p53-induced ROS are both decreased in p66Shc -/- Mouse 
Embryonic Fibroblasts (MEFs).  Possibly as a consequence of this, hydrogen-peroxide-
mediated release of cytochrome c is inhibited in p66Shc -/- MEFs, and transfection of 
p66Shc into these cells rescues the sensitivity.  Furthermore, there is a reduction in the 
amount of oxidation-damaged DNA of p66Shc -/- mice, as well as for mitochondrial DNA  
[73]. 
P66Shc appears to sensitively detect oxidative stress, i.e. the pathophysiological 
condition that has been often associated to cellular ageing, and is known to sensitize to a 
number of apoptotic challenges. P66Shc thus appears as a very promising link between 
phenomenological observations of the ageing process and the identification of the 
molecular mechanism responsible for the cellular changes. This is a fundamental step as it 
highlights potential targets for pharmacological intervention. 
In this scenario, the portion of p66Shc located into mitochondria seems to be 
fundamental for its role in oxidative stress. In fact, a fraction of p66Shc localizes to 
mitochondria [74, 75], where it binds to cytochrome c and acts as oxidoreductase, 
generating reactive oxygen species (ROS) and leading to organelle dysfunction and cell 
death [76] (Fig. 12). The route leading to p66Shc activation is still unclear. 
 
 
 32 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Model of p66Shc redox activity during mitochondrial apoptosis. Proapoptotic signals induce 
release of p66Shc from a putative inhibitory complex. Active p66Shc then oxidizes reduced cyt c (red) and 
catalyzes the reduction of O2 to H2O2. PTP opening by H2O2 then leads to swelling and apoptosis (figure from 
[76]). 
 
In this work, we address this task, focusing on the Ca2+-mediated signals in 
mitochondria. The rationale for this strategy stems from a number of experimental 
observations. Mitochondria receive, under stimulation by physiological agonists or toxic 
agents, Ca2+-mediated inputs [34, 77, 78]. These Ca2+ signals are decoded within 
mitochondria into effects as diverse as stimulation of aerobic metabolism and alterations of 
organelle structure leading to release of caspase cofactors into the cytoplasm [79]. Recent 
works showed that the responsiveness of mitochondria to Ca2+ signals can be tuned by                                          
the cross-talk with other signalling pathways and the activation of regulatory proteins, such 
as kinases. Specifically, we could show that some PKC isoforms (i.e. the components of a 
wide molecular repertoire of kinases differing for biochemical properties and activation 
mechanisms) specifically affect mitochondrial Ca2+ responses to agonists (by reducing 
them, such as PKC, or enhancing them, such as PKCζ) [80]. Interestingly, PKCs were 
proposed to be activated directly in conditions of oxidative stress [81]. 
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3.2 Results 
 
3.2.1 Effect of oxidative stress and the aging protein p66Shc on the mitochondrial Ca2+ 
homeostasis 
 
We used aequorin to monitor cellular concentrations of Ca2+, a green fluorescent 
protein with mitochondrial presequence (mtGFP) to monitor organelle structure (well 
explained in section 2), and other molecular tools to clarify the signalling route linking the 
oxidative challenge to the activation of p66Shc proapoptotic effect within mitochondria in 
mouse embryonic fibroblasts (MEFs). 
Using mtAEQ, we investigated organelle Ca2+ responses to adenosine triphosphate 
(ATP), an extracellular agonist that causes the release of Ca2+ from the endoplasmic 
reticulum. P66Shc −/− and wild-type MEFs showed similar responses of mitochondrial 
calcium ([Ca2+]mt) to ATP, both in amplitude and in kinetics (Fig. 13, A and B). This reflects 
a close similarity in the global Ca2+ signaling patterns. Indeed, the monitoring of 
concentration of free cytosolic Ca2+ ([Ca2+]cyt) showed that the [Ca2+]cyt rises evoked by 
ATP in p66Shc −/− and wild-type MEFs were virtually superimposable (Fig. 13, A and B, 
insets). 
To investigate the effect of an oxidative challenge, we treated cells for 30 minutes 
before the application of ATP with various concentrations of H2O2. Reduction of 
mitochondrial Ca2+ responses and fragmentation of the threedimensional mitochondrial 
network [33] was observed in wild-type MEFs (Fig. 13, A and a) several hours before signs 
of apoptosis (cell shrinkage and nuclear condensation, for example) were detected, 
whereas minor changes in the Ca2+ response and morphology were detected in p66Shc 
−/− MEFs (Fig. 13, B and b). This alteration in Ca2+ response was characteristically 
mitochondrial, because no difference in the ATP-dependent [Ca2+]cyt rise was detected 
between p66Shc −/− and wild-type H2O2-treated MEFs (Fig. 13, A and B, insets). The 
reintroduction of p66Shc reestablished sensitivity to H2O2 in p66Shc −/− MEFs (Fig. 13, C 
and c).  
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Fig. 13: Mitochondrial morphology and Ca2+ responses in p66Shc MEFs during oxidative stress. 
Mitochondrial and cytosolic (inset) Ca2+ homeostasis in wild-type (wt) (A) and p66Shc −/− (B) MEFs. wt: 
[Ca2+]mt) peak, 8.64 ± 0.32 mM; [Ca2+]cyt) peak, 2.90 ± 0.11 mM. p66Shc −/−: [Ca2+]mt peak, 8.71 ± 0.37 mM; 
[Ca2+]cyt peak, 2.91 ± 0.15 mM. The dotted traces show the effect of treatment with H2O2 (1 mM, 30 min.) on 
the ATP-dependent responses. wt: [Ca2+]mt peak, 5.84 ± 0.28 mM; [Ca2+]cyt peak, 2.60 ± 0.07 mM. p66Shc 
−/−: [Ca2+]mt peak, 7.87 ± 0.33 mM; [Ca2+]cyt peak, 2.7 ± 0.09 mM. (a and b) Analysis of mitochondrial 
structure in cells treated with or without H2O2 (1 mM, 30 min). (C and c) Reintroduced p66Shc reestablishes 
the [Ca2+]mt and morphology sensitivity to H2O2 in p66Shc −/− MEFs. [Ca2+]mt peak, 8.69 ± 0.51 mM; after 
H2O2, [Ca2+]mt peak, 5.76 ± 0.44 mM, P < 0.01. For all the experiments presented n ≥ 15. 
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Production of ROS by p66Shc [76] influences the opening of the mitochondrial permeability 
transition pore (PTP) [82]. We thus investigated whether the Ca2+ and morphology 
changes triggered by H2O2 could be prevented by the PTP blocker cyclosporine A (CsA). 
In CsA-treated wild-type MEFs, the rise in [Ca2+]mt evoked by ATP stimulation in the 
presence of H2O2 was largely restored (Fig. 14 A) and the integrity of the mitochondrial 
network was preserved (Fig. 14 a). On the contrary, no effect of CsA on p66Shc −/− (Fig. 
14 A, inset). Mitochondrial Ca2+ responses and morphology were not modified by H2O2 
application to p66Shc −/− MEFs in which either the p66ShcE132Q-E133Q mutant 
(p66Shcqq), incapable of binding cytochrome c [76] (Fig. 15, A and a), or the p66ShcS36A 
mutant [71] (Fig. 15, B and b) had been reintroduced, indicating that both the 
oxidoreductase activity of p66Shc and the phosphorylation of Ser36 are essential for the 
H2O2-induced proapoptotic changes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: Involvement of PTP in mitochondrial p66Shc action. Effect of treatment with CsA (4 mM, 10 
min.) on H2O2-dependent reduction of [Ca2+]mt responses in wt MEFs. [Ca2+]mt peak, 5.84 ± 0.28 mM in cells 
treated only with H2O2; 7.58 ± 0.33 mM, P < 0.01, in cells pretreated with CsA, then treated with H2O2 (A). No 
effect of CsA on p66Shc −/− cells was detected. [Ca2+]mt peak, 7.87 ± 0.33 mM in cells treated only with 
H2O2; 8.43 ± 0.54 mM in cells pretreated with CsA, then treated with H2O2 (inset). Morphology of H2O2- 
treated, CsA-pretreated cells (a). 
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Fig.15: Involvement of p66Shc binding to cytochrome c, and p66Shc phosphorylation in 
mitochondrial p66Shc action. Failure of the p66Shcqq mutant ([Ca2+]mt peak: control, 8.35 ± 0.71 mM; 
H2O2, 7.76 ± 0.35 mM) (A) or the p66ShcS36A mutant ([Ca2+]mt peak control, 8.58 ± 0.61 mM; H2O2, 7.74 ± 
0.64 mM) (B) to reestablish mitochondrial [Ca2+] sensitivity to H2O2 in p66Shc −/− MEFs. Morphology of 
H2O2-treated cells expressing the p66Shcqq (a) or p66ShcS36A mutants (b). 
  
 
 
 
 
 
 
 
 
 
 
B
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3.2.2 Effects of PKC β-dependent phosphorylation of p66Shc 
 
We demonstrate that phosphorylation of p66Shc on Ser36 is fundamental in order to 
exert its activity on mitochondrial Ca2+ uptake. So we investigate about the putative 
effector of this phosphorylation. 
Overexpression of the PKC isoform β reduces transient changes in [Ca2+]mt in HeLa 
[80], PKC β is expressed in MEF cells (Fig. 16 A) and phosphorylated p66Shc was 
detected after treatment of cells with H2O2 or with 12-Otetradecanoylphorbol 13-acetate 
(TPA), a PKC activator (Fig. 16 C). After application of H2O2, membrane staining of GFP-
tagged PKC β was detected by fluorescence microscopy (fig. 16 B), showing its activation 
[81]. Hispidin, a specific blocker of the PKC β isoform [83], inhibited p66Shc 
phosphorylation in both conditions (Fig. 16 C). 
Overexpression of PKC β mimicked the activation of the endogenous kinase by 
oxidative challenges, causing a reduction in [Ca2+]mt responses in wild-type MEFs (in which 
the putative downstream effector is present) but not in p66Shc −/− MEFs (Fig. 17 A). This 
effect was specific for PKC β. Moreover, when PKC β was inhibited pharmacologically with 
hispidin (Fig. 17 B) or its abundancewas decreased with RNA interference (RNAi) (Fig. 17 
C), the [Ca2+]mt peak was minimally affected by the application of H2O2. Similarly, hispidin 
treatment preserved mitochondrial morphology (Fig. 17 D). 
We verified whether PKC β inhibition reduced the apoptotic efficacy of H2O2 
treatment. We measured cell viability 8 hours after the addition of 1 mM H2O2 by counting 
surviving cells on the microscopy stage. Hispidin caused no change in cell viability in wild-
type cells but increased the number of cells surviving oxidative stress (29% ± 2.1 in H2O2-
treated cells versus 60% ± 4.75 in hispidin pretreated cells, expressed as a percentage of 
the cells counted on a coverslip not exposed to H2O2) (Fig. 18 A). To partially mimic an 
“aging” event, we analyzed mitochondrial Ca2+ responses in MEFs maintained in culture 
for 20 passages. In wild-type MEFs, the [Ca2+]mt responses gradually decreased with time 
in culture, whereas no alteration was observed in p66Shc −/− MEFs or in wild-type MEFs if 
the culture medium was supplemented with hispidin (Fig. 18 B). We also analyzed the 
effect of PKC β on other mitochondrial parameters: mitochondrial membrane potential (∆Ψ) 
and production of ROS. PKC β activation by TPA caused a gradual reduction in ∆Ψ in wild-
type but not in p66Shc−/− MEFs (Fig. 18 C). An increase in ROS production was observed 
shortly after infection of cells with an adenoviral vector driving PKC β expression: 
dihydroethidium fluorescence intensity (arbitrary units) 17.70 ± 1.2 versus 14.97 ± 1.3 in 
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nontransduced cells, supporting the view that PKC β triggers the oxidoreductase activity of 
p66Shc 
 
Fig. 16: Effects of PKC on p66Shc. Expression of PKC β protein in HeLa and MEFs cells was visualized by 
Western blot analysis (A). Fluorescence image of PKC β- GFP before and after an oxidative challenge (H2O2 
1mM, 30 min.) (B). Western blotting of control MEFs treated with H2O2 (500 µM, 10 minutes) or TPA 
(100ng/ml, 10 min.) using antibodies revealing phosphorylated (αpS36p66Shc) or non- phosphorylated 
(αSH2) p66Shc. + I, the cells were pre-treated (24 hours) with the PKC specific inhibitor hispidin (5 µM) (C). 
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Fig. 17: Effects of PKC β-dependent phosphorylation of p66Shc. (A) Effect of PKC β overexpression on 
[Ca2+]mt responses in wt ([Ca2+]mt peak, 5.84 ± 0.18 mM versus 8.64 ± 0.32 mM in nontransduced cells, 
P<0.01) and (inset) p66Shc −/− MEFs ([Ca2+]mt peak, 8.33 ± 0.37 mM versus 8.71 ± 0.37 mM in 
nontransduced cells). (B) Treatment of wt MEFs with hispidin (5 mM, 30 min.) prevents the H2O2-dependent 
reduction of [Ca2+]mt responses ([Ca2+]mt peak, 7.60 ± 0.46 mM versus 8.50 ± 0.43 mM in nontreated cells) 
and the alteration of mitochondrial structure (D). (C) Effects of depletion of PKC β with RNAi on H2O2- 
dependent reduction of [Ca2+]mt responses ([Ca2+]mt peak, 7.43 ± 0.49 mM versus 8.81 ± 0.56 mM in 
nontreated cells). Expression of PKC β after silencing is shown in the Western blot (inset). 
A
D
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Fig. 18: Effects of hispidin on cell viability. (A) Cell viability after the addition of 1 mM H2O2 in wt and 
hispidin pretreated (5 µM, 2 hours) MEFs (B) Mitochondrial Ca2+ responses in wt and p66Shc -/- MEFs 
maintained in culture. Wt cells cultured in presence of hispidin were also monitored. (C) Kinetics of 
tetramethyl rhodamine methyl ester (TMRM) fluorescence of wt and p66Shc −/− cells treated with TPA. 
FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), an uncoupler of oxidative phosphorylation, 
completely collapses the ∆Ψ. The traces are representative of single cell responses. 
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3.2.3 Pin1 induces p66Shc mitochondrial translocation after Ser36 phosphorylation 
 
We suspected that a possible link between PKC-dependent phosphorylation of 
p66Shc and its mitochondrial oxidoreductase activity was that phosphorylation mediated 
transfer of p66Shc from the cytosol to mitochondria. The prolyl isomerase Pin1 recognizes 
and induces cis-trans isomerization of pSer-Pro (or pThr-Pro) bonds, conferring 
phosphorylation-dependent conformational changes relevant for protein function [84, 85]. 
Moreover, Pin1 −/− MEFs are impaired in apoptosis after exposure to ultraviolet (UVc) 
radiation [86]. We identified a putative consensus for Pin1 binding (Ser36/Pro37) in 
p66Shc. Pulldown experiments with Pin1 linked to glutathione S-transferase (GST-Pin1) 
showed that Pin1 bound to p66Shc after exposure of cells to UVc radiation that caused 
phosphorylation of p66Shc. This interaction appeared to be phosphorylation dependent 
because it was reduced by treatment of cell extracts with calf intestinal phosphatase (CIP). 
Furthermore, the nonphosphorylatable mutant p66ShcS36A did not show detectable 
binding to Pin1 (Fig. 19 A). 
We investigated the mitochondrial effects of H2O2 treatment in Pin1 −/− MEFs. In Pin1 
−/− cells, the H2O2-dependent reduction of the [Ca2+]mt peak was smaller than that of wild-
type MEFs (Fig. 19 B). Overexpression of Pin1 sensitized cells to weaker oxidative stress. 
When wild-type MEFs were subjected to mild oxidative stress (100 µM H2O2 for 15 min. 
instead of 1 mM for 30 min.), no alteration in the agonist-dependent [Ca2+]mt transient was 
detected, whereas in Pin1 overexpressing cells, the peak was reduced (Fig. 19 C). In 
certain substrates, the phosphoserine-proline (phosphoS-P) sites, once isomerized by 
Pin1, are recognized and dephosphorylated by PP2A [85]. In cells treated with okadaic 
acid (PP2A inhibitor), the reduction in agonist-dependent [Ca2+]mt responses was markedly 
smaller (Fig. 19 D) than that in wild-type cells, which might suggest that dephosphorylation 
by PP2A follows Pin1 recognition and is necessary for the mitochondrial effects of p66Shc. 
Finally, we tested the hypothesis that Pin1-dependent isomerization of p66Shc 
enhances the transfer of the protein to the organelle. We evaluated the mitochondrial pool 
of p66Shc in wild-type and Pin1 −/− MEFs by subcellular fractionation and immunoblotting 
(Fig. 19 E). In wild-type cells, oxidative stress increased the amount of p66Shc within 
mitochondria (~+100%). This effect appeared to depend on PKC activity, because a similar 
increase was evoked by treatment of cells with TPA, and hispidin inhibited the effects of 
H2O2 treatment. Blots of total homogenate showed only a small increase in the total 
amount of p66Shc (~+15%) [75], indicating that there was net translocation of p66Shc to 
the organelle. In Pin1 −/− MEFs, the mitochondrial fraction of p66Shc was smaller, either 
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at rest or after treatment with H2O2 or TPA. TPA had no detectable effect on localization of 
p66Shc in the Pin1 −/− cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19: Pin1 induces p66Shc mitochondrial translocation after Ser36 phosphorylation. (A) Total 
lysates from Phoenix cells (φnx) transfected with p66Shc or its S36A mutant, UV-irradiated and/or treated 
with CIP, were subjected to GST or GST-Pin1 pull-down followed by immunoblotting with antibody to Shc. (B) 
Effect of H2O2 on the ATP-dependent [Ca2+]mt responses in Pin1 −/− ([Ca2+]mt peak, 8.64 ± 0.49 mM in control 
versus 6.98 ± 0.46 mM in H2O2 treated) and (inset) wt ([Ca2+]mt peak, 8.41 ± 0.22 mM in control versus 5.02 ± 
0.39 mM, P < 0.01 in H2O2 treated) MEFs. (C) Effect of 100 mM H2O2 on [Ca2+]mt responses in Pin1 
overexpressing MEFs ([Ca2+]mt peak, 8.60 ± 0.58 mM in control versus 7.26 ± 0.26 mM H2O2 treated, P<0.05) 
and (inset) in wt MEFs ([Ca2+]mt peak, 8.64 ± 0.49 mM in control versus 8.56 ± 0.31 mM, H2O2 treated). (D) 
Effects of okadaic acid (1 mM, 1 hour) on H2O2-dependent reduction of [Ca2+]mt responses ([Ca2+]mt peak, 
7.58 ± 0.33 mM versus 6.83 ± 0.24 mM, in okadaic acid pretreated cells before and after H2O2 treatment, 
respectively). (E) Western blot of p66Shc protein levels in the mitochondrial fraction and in the cell 
homogenate from wt and Pin1 −/− MEFs. 
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3.3 Discussion 
 
The pathway emerging from these data is the following (Fig. 20): during oxidative 
stress PKC β is activated and induces p66Shc phosphorylation, thus allowing p66Shc to 
be recognized by Pin1, isomerised and imported into mitochondria after dephosphorylation 
by type 2 protein serine/threonine phosphatase (PP2A). At this point, the protein 
translocated into the appropriate cell domain, can exert the oxidoreductase activity, 
generating H2O2 and inducing the opening of PTP. This event in turn perturbs mitochondria 
structure and function (as revealed by the reduced Ca2+ responsiveness and the alteration 
of mitochondrial three-dimensional structure). Caspase cofactors, such as cytochrome c, 
are released and the cell progresses into apoptosis. By this way p66Shc may regulate the 
mitochondrial clock controlling the lifespan. Overall, these results thus identify and clarify a 
novel signalling mechanism, which is operative in the pathophysiological condition of 
oxidative stress, and may open new possibilities for pharmacologically addressing the 
process of organ deterioration during aging. In addition to this route, p66Shc appears to 
act through different pathways. Indeed, it has been shown that p66Shc enhances oxidative 
stress-induced apoptosis also by participating in the phosphorylation-induced repression of 
Forkhead transcription factors, which regulate expression of several antioxidant enzymes 
[87]. Consistent with this, p66Shc knockout mice exhibit higher catalase activity, and mice 
with extra catalase in their mitochondria lived about 20% more than controls and were less 
likely to develop cataracts, but they did not appear to age more slowly and their extended 
lifespan appeared to derive from a decrease in cardiac diseases throughout the entire 
lifespan [88] further emphasizing the mitochondrial role of p66Shc. 
Finally, it should be remembered that the “aging” role of p66Shc appears in contrast 
with a recent publication showing that p66Shc is highly expressed in fibroblasts from 
centenarians [89]. An intriguing reconciling hypothesis could be the existence of some 
defects on the mitochondrial pathway of p66Shc (presented in Fig. 20) on centenarians 
that prevents the mitochondrial import of p66Shc and in turn its pro-aging properties, while 
leaving other biological functions (e.g., the production of low levels of ROS necessary in 
differentiation) unaffected. 
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Fig. 20: Signal transduction pathway of p66Shc in oxidative condition. Phosphorylated p66Shc may 
serve as an integration point for many signaling pathways that affect mitochondrial function and longevity 
(figure from [90]). 
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4. Intramitochondrial calcium regulation by the FHIT gene product 
sensitizes to apoptosis 
 
4.1 Introduction 
 
The fragile histidine triad (FHIT) gene, isolated by positional cloning, encompasses 
the most common human fragile site FRA3B at 3p14.2. This chromosomal region is 
involved in hemizygous and homozygous deletions, and indeed mutations of FHIT were 
demonstrated in a large variety of human tumors [91-94]. FHIT encodes a 17-kDa protein 
(Fhit) that is abundantly expressed in normal human lung, stomach, kidney, and other 
epithelial tissues, whereas most tumors and tumor-derived cell lines do not express Fhit or 
show markedly reduced levels of the protein [95]. Fhit knock-out mice are more susceptible 
to cancer development than their wild-type counterparts [96], and FHIT gene therapy can 
prevent and reverse tumors in carcinogen-exposed Fhit-deficient mice [97]. However, the 
precise molecular mechanism involved in the antitumor function of FHIT remains largely 
unclear. Fhit is partly localized in mitochondria, and interaction with Hsp60/Hsp10 could be 
important for correct refolding after import and Fhit stability [98]. This compartmentalization 
of Fhit could reveal a transcription-independent regulation of cell fate. Indeed, mitochondria 
are at the crossroad of numerous apoptotic pathways that synergize in triggering the 
morphological transitions underlying the release of proapoptotic factors into the cytoplasm 
[29, 99, 100]. In most cases, Ca2+ acts as a fundamental sensitizing factor, and anti-
apoptotic proteins, such as Bcl-2, have been shown to reduce ER Ca2+ levels, and agonist 
dependent release and mitochondrial loading [35, 101, 102]. 
Different agents induce Ca2+ release from the ER Ca2+ store through the IP3R Ca2+ release 
channel [103]. Consequent mitochondrial Ca2+ uptake, via a yet unidentified Ca2+ channel 
of the inner mitochondrial membrane (the mitochondrial Ca2+ uniporter, MCU), regulates 
different processes: Aerobic metabolism [104], release of caspase cofactors [33], and 
feedback control of neighboring ER or plasma membrane Ca2+ channels [105, 106]. The 
ER and mitochondria are thus crucial nodes at which intracellular Ca2+ fluxes and 
functional outcomes are governed [107]. Their relevance to the control of cell survival is 
supported by several reports showing that modulation of mitochondrial Ca2+ accumulation 
(because of modification of the molecular repertoire of the cells) modifies cellular sensitivity 
to Ca2+-mediated apoptotic stimuli [35, 101, 102]. 
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We thus investigated whether Fhit has a role in the control of Ca2+ fluxes across the 
mitochondrial membranes. The results demonstrated that Fhit increases the affinity of the 
mitochondrial machinery for Ca2+ accumulation into the organelle, thus enhancing 
mitochondrial Ca2+ uptake triggered by physiological agonists and apoptotic challenges. 
The increase in mitochondrial Ca2+ loading, by favoring the elimination of altered or 
damaged cells by apoptosis, may play a key role in the mechanism of action of this 
important tumor suppressor. 
 
 
4.2 Results 
 
4.2.1 Subcellular localization of Fhit and effect on Ca2+ homeostasis 
 
The intracellular location (Fig. 21 A) and expression level (Fig. 21 B) of endogenous 
and overexpressed Fhit were first verified. Immunofluorescence experiments revealed a 
diffuse cytosolic and nuclear staining and a stronger labeling of filamentous structures 
corresponding to mitochondria (as confirmed by the merged image with cotransfected 
mitochondrial GFP, mtGFP) (Fig. 21 A). Upon overexpression, the fraction of nuclear Fhit 
appears increased, compared with the cytosol (compare Fig. 21 Ai and Aii). Moreover, the 
mitochondrial staining of Fhit was confirmed also after permeabilization of the plasma 
membrane using digitonin to remove the cytosolic pool of the protein (Fig. 21 C). 
Then, calcium measurements were carried out, using aequorin-based recombinant 
probes [108]. Fig. 21 D shows the results of a typical experiment. Where indicated, HeLa 
cells were exposed to histamine (100 µM), causing the generation of inositol 1,4,5 
trisphosphate (IP3) and the consequent release of Ca2+ from the ER. No difference in 
cellular Ca2+ handling was observed between Fhit-overexpressing and control cells. 
Indeed, both groups of cells showed very similar luminal ER Ca2+ concentrations at rest 
([Ca2+]er) (control 461.00 ± 22.90 µM vs. Fhit 471.50 ± 25.10 µM) and comparable release 
kinetics upon histamine addition. Accordingly, the transient rises of Ca2+ concentration in 
the cytosol ([Ca2+]cyt) and in the mitochondrial matrix ([Ca2+]mt) elicited by the agonist were 
very similar ([Ca2+]cyt, control 2.82 ± 0.05 µM vs. Fhit 2.92 ± 0.08 µM; [Ca2+]mt, control 82.20 
± 4.70 µM vs. Fhit 85.70 ± 3.79 µM). 
The situation changed at a lower agonist dose (10 µM histamine). The aequorin 
probes showed very similar release kinetics from the ER, slower than with 100 µM 
histamine (control 3.21 ± 0.40 µM/sec. vs. Fhit 3.32 ± 0.29 µM/sec.), and superimposable 
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[Ca2+]cyt peaks (control 2.67 ± 0.08 µM; Fhit 2.66 ± 0.08 µM) (Fig. 21 E). Conversely, in 
Fhit-overexpressing cells, the [Ca2+]mt increase was approximately 30% greater (control 
13.01 ± 0 75 µM vs. Fhit 16.74 ± 1.44  µM) (Fig. 21 E). 
This effect was not cell type-specific, as the same results were obtained in A549 cells 
(Fig. 22 A), nor could it be related to overexpressed protein, as shRNA silencing of 
endogenous Fhit in HeLa cells caused the expected opposite effect (control 13.23 ± 1.92 
µM vs. shRNA Fhit 10.93  ± 1.79 µM) (Fig. 22 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Subcellular localization of Fhit and effect on Ca2+ homeostasis. (A) Immunofluorescence 
labeling of Fhit (Left), mtGFP visualization (Middle), and merged image (Right) in HeLa cells. (I) Control, (II) 
Fhit-overexpressing cells. (B) Western blotting of Fhit and β tubulin as reference. Arrowheads denote the 
position of endogenous (lower) and His-6-tagged (higher) Fhit bands in mock-transfected (Mock) and Fhit-
overexpressing (Fhit) HeLa cells. The level of overexpression is typical of the results obtained in all of the 
experiments of this paper. (C) Immunofluorescencelabeling of overexpressed Fhit after plasma membrane 
permeabilization with digitonin. (D and E) [Ca2+] measurement in the ER (Left), cytosol (Middle), and 
mitochondria (Right) in controls (gray line) and Fhit-overexpressing cells upon 100 µM (D) and 10 µM (E) 
histamine. 
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Fig. 22: Not cell type-specific role of Fhit and ShRNA Fhit effect on Ca2+ homeostasis. (A) [Ca2+]mt 
measurements in control and in Fhit-transduced A549 cells after stimulation with histamine 10 µM. (B) 
[Ca2+]mt measurements in control and shRNA-Fhit-transduced HeLa cells. Inset, Fhit immunoblotting to 
estimate the level of shRNA Fhit silencing. 
 
4.2.2 Assessment of mitochondrial Ca2+-uptake capacity in permeabilized and intact cells  
 
We then investigated the possible mechanism of the increased uptake at submaximal 
agonist stimulation. Rapid uptake into mitochondria depends on close interactions with the 
ER [109, 110], as well as on the state of fusion/fission of the organelle network [111]. 3D 
reconstruction of mtGFP-labeled of mitochondria showed no difference in distribution and 
shape between Fhit-overexpressing and control cells (Fig. 23 A). As to the driving force for 
Ca2+ accumulation, loading of the potential-sensitive tetramethyl rhodamine methyl ester 
(TMRM) dye revealed no difference in the transmembrane potential (∆Ψ) (Fig. 23 B). 
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Fig. 23: Fhit-overexpression doesn’t affect mitochondrial membrane potential and morphology. (A) 
Mitochondrial morphology in Fhit-transfected and control HeLa cells as revealed by mtGFP visualization. (B) 
TMRM fluorescence level of control and Fhit cells, before and after treatment with FCCP (carbonyl cyanide p-
trifluoromethoxyphenylhydrazone), to collapses mitochondrial ∆Ψ. 
 
 We thus concluded that the explanation of our results most likely resided in the 
increased affinity of the molecularly undefined transporter (the mitochondrial Ca2+ 
uniporter, MCU). We explored this possibility by measuring mitochondrial Ca2+ uptake in 
permeabilized cells and by visualizing the hotspots of rapid mitochondrial uptake in intact 
cells. In the former case, transfected HeLa cells were perfused with a solution mimicking 
the intracellular milieu (IB), supplemented with 2 mM EGTA, and permeabilized with 20 µM 
digitonin for 1 min. 
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Then, the perfusion buffer was changed to IB with an EGTA-buffered [Ca2+] of 1 µM, 
eliciting a gradual rise in [Ca2+]mt that reached a plateau value of approximately 30 µM (Fig. 
24 A). In Fhit-overexpressing HeLa cells, the [Ca2+] increase was larger and faster than in 
controls (Vm, mean of first 15 sec., control 0.53 ± 0.01 µM/sec. vs. Fhit 0.79 ± 0.01 
µM/sec.) and reached an approximately 20% higher plateau. A coherent picture emerged 
from single-cell imaging experiments in HeLa cells with a GFP-based mitochondrial probe, 
2 mtRP [112]. Time-lapse series of high resolution images were acquired at 5–10 
frame/sec. and visualized as 2D image series of the whole mitochondrial network. These 
data allowed calculation of the number of localized [Ca2+]mt increases (hotspots), visualized 
in a pseudocolor scale, and evaluation of their diffusion across mitochondria. 
After application of 10 µM histamine, mitochondrial Ca2+ uptake initiated at 
preferential points of the mitochondrial network and the [Ca2+] increase traveled along the 
mitochondrial profiles, saturating the relatively high-affinity probe. In Fhit-overexpressing 
cells, the number of hotspots was markedly greater than in controls (Fig. 24 B). This 
heterogeneity, and the increased number of hotspots in Fhit-overexpressing cells, was 
quantified by calculating the standard deviation of the relative fluorescence changes over 
individual mitochondrial objects (control 10.55 ± 0.95 vs. Fhit 16.06 ± 1.45, P < 0.01) (Fig. 
24 C). Based on previous observations that stimulations with agonists evoking 
mitochondrial Ca2+ signals cause parallel increases in intracellular ATP [70], we also 
measured mitochondrial ATP levels ([ATP]mt) in control and Fhit-overexpressing HeLa 
cells. For this purpose, the mitochondria-targeted ATP probe luciferase (mtLUC) was 
cotransfected, as previously reported (Fig. 24 D) [70]. 
Interestingly, overexpression of Fhit increases the [ATP]mt rise evoked by 10 µM 
histamine, thus demonstrating that (i) also at submaximal agonist challenges the [Ca2+]mt 
rise is decoded into a stimulation of mitochondrial aerobic metabolism and (ii) Fhit plays a 
role in the metabolic effect of mitochondrial Ca2+ signals. 
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Fig. 24: Assessment of mitochondrial Ca2+-uptake capacity in permeabilized and intact cells. (A) 
Mitochondrial Ca2+-uptake in permeabilized cells: Representative traces (Left) and average speed (Right). 
Where indicated (Ca2+ 1 µM) the medium was switched from IB/EGTA to IB/1 µM [Ca2+]. (B) Rapid imaging of 
the [Ca2+]mt increase elicited by 10 µM histamine, in control (mtRP/Control) and Fhit-overexpressing 
(mtRP/Fhit) HeLa cells. The images in the panel show the fluorescence changes of the mtRP probe, 
expressed in a pseudocolor scale (warmer colors revealing the [Ca2+]mt increases). (C) Total number of 
generated mitochondrial Ca2+ hotspots, plotted through time after stimulation. (D) Mitochondrial [ATP] 
changes in control and Fhit-overexpressing HeLa cells. 
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4.2.3 The [Ca2+]mt is affected by a mitochondrial Fhit chimera 
 
We then investigated whether the mitochondrial signaling alteration is caused by the 
fraction of Fhit protein localized to mitochondria. To fully sort Fhit to mitochondria, a 
mitochondrial targeting sequence was appended at its N terminus (mtFhit; Fig. 25 A). 
Indeed, immunofluorescence experiments showed only the typical filamentous structure of 
the mitochondrial network (Fig. 25 A). We then carried out mitochondrial Ca2+ 
measurements, using the mtAEQ, erAEQ, and cytAEQ probes, cotransfected with mtFhit 
(mtFhit). Upon submaximal histamine challenge (10 µM), mtFhit-overexpressing cells 
underwent a [Ca2+]mt rise that was markedly greater than that of controls and comparable 
to that of Fhit-overexpressing cells (mtFhit 16.53 ± 1.85 µM), whereas the [Ca2+]er and 
[Ca2+]cyt values were comparable to those of control cells. 
These data show that a Fhit variant with exclusive mitochondrial localization fully 
retains the effect on mitochondrial Ca2+ signaling of the wild-type protein (Fig. 25 B). We 
then labeled the ER and the mitochondria with a GFP-based probe (erGFP) and 
MitoTracker-Red to investigate organelle morphology in mtFhit-transfected and control 
cells. No alteration was observed in the morphology of the two organelles nor in the 
number and location of the contacts. Then ∆Ψ was measured with TMRM; also in this 
case, no difference was observed between mtFhit-expressing and control cells. We thus 
concluded that mtFhit does not exert damaging effects on mitochondrial morphology, on 
the functional interaction with the ER, and in the generation of the membrane potential 
across the inner membrane. 
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Fig. 25: Subcellular localization and effect on Ca2+ signaling of mtFhit. (A) Map of the mtFhit cDNA and 
immunolocalization of the expressed protein. (B) [Ca2+] measurement in the mitochondria, ER (control 438 ± 
26.90 µM vs. Fhit 411 ± 35.60 µM), and cytosol (control 2.48 ± 0.03 µM vs. Fhit 2.50 ± 0.03 µM) in controls 
(gray) and mtFhit-overexpressing cells (black) upon addition of 10 µM histamine. 
 
4.2.4 The mitochondrial fraction of Fhit potentiates apoptotic effect of menadione 
 
We then investigated the functional consequences of the signaling alteration. Various 
apoptotic challenges appear to use Ca2+ as a sensitizing cofactor, e.g., C2-ceramide, 
oxidative stress (menadione, H2O2) or arachidonic acid [105, 113-115]. These stimuli 
induce movement of Ca2+ from the ER to mitochondria, leading to Ca2+ overload, OMM 
permeabilization, and caspase-mediated cell death. To verify whether Fhit affects Ca2+ 
homeostasis and cell survival in apoptotic conditions, we investigated the effects of 
menadione. Treatment with menadione caused a small, transient [Ca2+]cyt rise followed by 
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a lower, sustained plateau (Fig. 26 A). As expected, this low-amplitude [Ca2+]cyt increase 
correlated with a marginal uptake of Ca2+ into mitochondria (Fig. 26 B). 
Interestingly, also in the case of the apoptotic challenge the [Ca2+]mt, but not the 
[Ca2+]cyt rise, was markedly greater in Fhit-overexpressing cells. We then correlated the 
Ca2+ data with the efficacy of the oxidizing agent in causing cell death, by 2 approaches: 
the microscopic assessment of cell survival (apoptotic counts), after coexpression of a 
fluorescent marker (mtGFP), and Annexin V-based measurement of apoptosis. In the first 
case, a decrease in the percentage of fluorescent cells correlates with a proapoptotic role 
of the expressed protein. As expected, after menadione treatment a substantial reduction 
in the number of Fhit-overexpressing cells was observed (control ∆% 1.94 ± 6.75 vs. Fhit -
36.79 ± 7.25) (Fig. 26 C). Interestingly, the reduction was greater with mtFhit (∆% -45.48 ± 
7.39). 
In Annexin V measurements, Fhit-overexpressing and control cells were labeled with 
Alexa Fluor 488 Annexin V, sorted by flow cytometry, and expressed as percentage of 
strongly fluorescent cells (Fig. 26 D). In basal conditions, higher levels of Annexin V 
labeling were detected in Fhit-overexpressing HeLa cells (21.1%) compared with controls 
(13%). After a 2-h treatment with menadione, the percentage of Annexin-positive cells 
increased to 38.3% (16.6% of nontransfected cells). With mtFhit, the percentage of 
Annexin V-positive cells was comparable to controls in basal conditions (12%), but was 
greatly measured after treatment with menadione (16.6%, 38.3%, and 52.5% for control, 
Fhit, and mtFhit-transfected cells, respectively). Overall, these data indicate that 
mitochondrially localized Fhit does not influence basal levels of apoptosis, but greatly 
sensitizes to apoptotic challenges, in good agreement with the view of a Ca2+-mediated 
intramitochondrial potentiation of apoptotic routes. 
Finally, we investigated whether other putative functions of Fhit, which have been 
proposed to cooperate in tumor suppression but are unlikely to be ascribed to a 
mitochondrial effect, are also shared by mtFhit. We focused on cell cycle control [116] and 
carried out FACS sorting of cells after DNA labeling with propidium iodide (Fig. 27). Fhit-
overexpressing cells showed an increased number of cells in the G2 phase or at the S-G2 
boundary, as reported in H460 cells [117]. Conversely, mtFhit does not share this property 
with Fhit, as the distribution of cells in G0/G1, S, and G2/M is very similar to that of control 
cells (G0/G1: 48.4%, 35.1%, 47.1%; S: 8.2%, 9.6%, 7.9%; G2/M: 36.8%, 42.7%, 36.4% for 
control, Fhit, and mtFhit-transfected cells, respectively). 
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Fig. 26: The mitochondrial fraction of Fhit potentiates apoptotic challenges. (A) [Ca2+]cyt and (B) [Ca2+]mt 
increases elicited by 1mM menadione. (C and D) Assessment of cell viability via apoptotic counts (C) or 
Annexin V labeling (D) in controls, Fhit and mtFhit overexpressing cells, as indicated. In panel D, the 
percentage of cells over a common arbitrary level of fluorescence is indicated. 
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Fig. 27: Effect of Fhit and mtFhit overexpression on cell cycle. Distribution of HeLa cells in the cell cycle, 
as estimated by propidium iodide staining of DNA. The percentage of cells in G0/G1, S, and G2 is reported in 
each graph.  
 
4.3 Discussion 
 
Our previous observation that Fhit protein is localized within mitochondria and 
engages protein-protein interactions with resident proteins such as ferredoxin [98] 
highlighted the possibility that it could tune apoptotic signals reaching the mitochondrial 
checkpoint. 
We pursued this hypothesis, focusing on Ca2+ signaling, based on a large body of 
experimental evidence by us and other groups that demonstrates the importance of 
mitochondrial Ca2+ loading for triggering the morphological transitions of apoptosis [29, 
100, 118, 119]. The results were very striking, as not only they revealed a marked 
potentiation of the matrix [Ca2+] transients elicited by physiological stimuli and apoptotic 
agents, but also identified a mechanism for this effect. 
Fhit is an enigmatic protein, exerting an AP3Ahydrolase activity that is not required for 
its tumor suppression function [120]. To date, the exact mechanism by which Fhit exerts its 
antitumor activity remains obscure. A considerable body of evidence points to the role of 
Fhit in apoptosis induction and cell cycle regulation, including its role as modulator of DNA 
damage checkpoint response [96], but the molecular pathways of the apoptotic activity of 
Fhit remain elusive. Our results bring this tumor suppressor to the core mechanism of the 
intrinsic pathway of apoptosis, participating in the regulation of the critical mitochondrial 
steps. This effect is mediated by the fraction of Fhit localized in mitochondria [98], whereas 
other reported functions of Fhit, such as the putatively transcriptional control of the cell 
cycle are unaffected by an exclusively mitochondrial Fhit chimera. These data thus 
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suggest that the complex intracellular distribution of Fhit may underlie a synergistic effect 
of different protein pools (cell cycle block, induction of apoptosis) that cooperate in 
repairing or eventually clearing DNA-damaged cells. As to the mechanism itself, the data 
provide a radically different picture from the numerous previous examples of pro and anti-
apoptotic proteins acting on calcium signaling. The [Ca2+]ER levels were shown to be 
modulated by the Bcl-2 family members, with Bcl-2 itself reducing the state of filling of the 
Ca2+ store [35], and Bax and Bak counteracting this effect [114]. In turn, the partial 
emptying reduces mitochondrial Ca2+ loading and, hence, the efficacy of various apoptotic 
challenges [33, 114]. In the case of neurodegenerative signals and of the proapoptotic HBx 
protein, mitochondrial Ca2+ overload was shown to depend on the caspase-mediated 
cleavage of the plasma membrane Ca2+ ATPase (PMCA) that impairs the termination 
mechanism of the Ca2+ signal and amplifies and extends the cytosolic Ca2+ increases [36, 
121]. 
Here, we report that Fhit does not alter cytoplasmic Ca2+ signals and acts specifically 
on mitochondria by modifying the affinity of the MCU. Accordingly, mitochondrial Ca2+ 
signals are minimally affected by supramaximal agonist stimulations, but are markedly 
increased at lower, more physiological agonist concentrations. This mechanism of action 
appears very effective in apoptosis for 2 reasons. The first reason is that apoptotic 
challenges, such as the lipid mediator C2-ceramide [33] and oxidative stress, such as that 
caused by menadione or H2O2 and used in this paper, have been shown to empty Ca2+ 
stores, but do so with a slow kinetics. Accordingly, mitochondrial uptake is relatively 
modest, because the low affinity of the MCU requires the generation of high [Ca2+] 
microdomains at the ER/ mitochondria contacts [109, 110]. If, however, the affinity of the 
MCU is increased by Fhit, also under those conditions mitochondria accumulate a large 
Ca2+ load, allowing the opening of the PTP and the induction of cell death, as directly 
shown in the experiment of Fig. 26. In addition, physiological Ca2+-mediated signals may 
synergize with PTP sensitizers (e.g., ceramide or alcohol), initiating slow waves of 
depolarization and Ca2+ release propagating through the cell [113]. In this picture, Fhit, by 
sensitizing mitochondria, increases the possibility that any stimulatory input to the cell 
reaches the threshold for initiating the apoptotic Ca2+ wave. The observation of Fig. 24 that 
Fhit increases the number of hotspots (i.e., initial sites of Ca2+ uptake in mitochondria) 
strongly supports this scenario. 
Finally, the identification of Fhit as a protein modulator of the MCU can open the way 
to proteomic approaches for solving the molecular enigma of mitochondrial Ca2+ 
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homeostasis. Indeed, despite the growing interest in this process, the MCU remains 
undefined at the molecular level, and all of the efforts for biochemically identifying it have 
been frustrated by the lack of specific tools for labeling the proteins (the best characterized 
inhibitor, Ruthenium Red, binds unspecifically to a wide array of proteins). The 
demonstration that Fhit binds, directly or indirectly, to the MCU gives the possibility of 
analyzing the mitochondrial complexes in which it is engaged, with the aim of identifying 
the molecular component(s) of the MCU. 
Overall, understanding the mechanisms through which Ca2+ signals can be shifted 
from regulators of cellular functions to pathological effectors and the role of mitochondria 
as decisive checkpoints is an exciting task in biomedical research and a promising 
opportunity for developing drugs. The observation that Fhit is directly engaged in this 
process deepens our insight into the functioning of this important tumor suppressor and 
further stresses the relevance of mitochondrial Ca2+ homeostasis in cancer-related 
apoptosis. 
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5. Akt kinase reducing endoplasmic reticulum Ca2+ release protects 
cells from Ca2+-dependent apoptotic stimuli 
 
5.1 Introduction 
 
Protein kinase B or Akt, is a serine/threonine kinase, which in mammals comprises 
three highly homologous members known as PKB α (Akt1), PKB β (Akt2), and PKB γ 
(Akt3) [122]. 
Key roles for this enzyme can be found in cellular processes such as glucose 
metabolism, cell proliferation, apoptosis, transcription and cell migration [123, 124]. Akt 
functions to promote cell survival through several pathways [123, 125, 126]. The precise 
mechanisms by which Akt prevents apoptosis are not completely understood. 
The major structural features of the Akt proteins are illustrated in Fig. 28. Each 
isoform possesses an N-terminal pleckstrin homology (PH) domain of approximately 100 
amino acids. Recent detailed structural examination of Akt PH domains reveals similarity to 
PH domains found in other signalling molecules that bind 3-phosphoinositides [127, 128]. 
This, together with evidence from earlier in vitro studies, indicates that the PH domain 
mediates binding of Akt to 3-phosphoinositides. The PH domain is followed by the kinase 
catalytic domain, which shows a high degree of similarity to those found in PKA and PKC 
[129, 130]. Also present in this region is a threonine residue (Thr308 in Akt1) whose 
phosphorylation is necessary for activation of Akt. Following the kinase domain is a 
hydrophobic C-terminal tail containing a second regulatory phosphorylation site (Ser473 in 
Akt1). 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Structure of different isoforms of Akt. 
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Phosphorylation at Thr308 and Ser473 occurs in response to growth factors and other 
extracellular stimuli and is essential for maximal Akt activation [131]. Akt may also be 
phosphorylated on Ser124 and Thr450 but neither of these sites appears to regulate Akt 
activity and their phosphorylation does not change following cell stimulation [131].  
In particular, full activation of Akt is a multi-step process, and several proteins 
responsible for each step have been identified [132]. Some stimuli can promote the 
activation of Akt through the activation of receptor tyrosine kinases. One of the most 
significant findings in the early stages of Akt research was its PI3-kinase-dependent 
activation [133-135]. Akt is also activated by receptor tyrosine kinases such as platelet 
derived growth factor receptor (PDGF-R), insulin, epidermal growth factor (EGF), basic 
fibroblast growth factor (bFGF) and insulinlike growth factor I (IGF-I). Membrane-targeting 
processes are important for PI3-kinases to get access to their substrates, as they are 
anchored in the plasma membrane. At this level, Akt is phosphorylated in two different 
sites, Thr308 and Ser473 [131], by PDK1 [136, 137] and mTOR complex 2 [138], 
respectively. These two sites are necessary and sufficient for full activation of Akt, which 
can translocate to different organelles, such as the endoplasmic reticulum (ER), the 
nucleus and mitochondria. The model of Akt activation is showed in Fig. 29. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29: Schematic model of Akt activation. 
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Forced membrane localization of Akt through its myristoylation/palmitylation is 
sufficient for maximal phosphorylation of key aminoacids and in turn for its full activation. 
The activity of this plasma membrane targeted Akt chimera (m/p-AKT1) is 60-fold higher 
compared with the unstimulated wild-type enzyme [139] and it is widely utilized in studying 
the effects of Akt in several signal transduction pathways [140-142]. 
Akt is a growth-factor-regulated protein kinase that phosphorylates in vitro and in vivo 
the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) (Fig. 30 B), thanks to the presence of 
a consensus substrate motif that is conserved in all three IP3R isoforms  (Fig. 30 A) [143]. 
The IP3R is involved in Ca2+ mobilization from intracellular stores, where channel activity is 
largely under the control of the IP3 binding. IP3R is involved in fundamental processes such 
as fertilization, meiosis, and mitosis and it has been reported that several proteins interact 
with IP3Rs [144]. Some of these have a modulatory role. Indeed, in addition to Akt 
mentioned above, the IP3R is also a substrate for several other protein kinases including 
calmodulin dependent protein kinase II [145], protein kinase C [80, 146] and MAP kinases. 
As mentioned before, the main role of the IP3R is releasing Ca2+ into the cytoplasm and to 
other effector systems (such as mitochondria). Ca2+ is recognized to be a fundamental 
second messenger involved in fertilization, proliferation, muscle contraction and secretion 
[103, 147]. As a second messenger, Ca2+ exerts its role inside the cell, where its 
concentration is highly controlled. The extent of Ca2+ signal is also a key determinant of the 
intrinsic apoptotic pathway, thus controlling cell fate under physiological and pathological 
conditions [31]. There is general agreement in the literature that Ca2+ efflux from the ER 
and Ca2+ accumulation into the mitochondria are linked to the effects of various apoptotic 
stimuli [31]. The task of this work was to evaluate the effect of the overexpression of a 
constitutively active AKT1 on subcellular Ca2+ homeostasis in transiently transfected HeLa 
cells, i.e. the same cell model in which the effects of Bcl-2 and Bax on Ca2+ signaling were 
previously detected and analyzed [33, 35, 36]. We then analyzed the effects of Akt 
overexpression on the cytosolic Ca2+ signal elicited by apoptotic stimuli such as oxidative 
stress and arachidonic acid, as they act through mitochondrial Ca2+ overload and 
activation of the intrinsic apoptotic pathway following to Ca2+ release from the ER. 
Altogether our data suggest that the alteration of Ca2+ fluxes through the IP3R is a key 
component of the protective action of Akt against apoptosis induced by stimuli acting in a 
Ca2+-sensitive manner. 
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Fig. 30: Akt phosphorylates IP3Rs. (A) All three isoforms of IP3Rs present a conserved consensus 
sequence for Akt phosphorylation. (B) the residue of Serine phosphorylated by Akt is located at C-terminal of 
IP3R, into the gatekeeper domain (figure A from [143], figure B from [148]). 
 
 
5.2 Results 
 
5.2.1 Akt drastically reduces ER Ca2+ release, while leaving ER Ca2+ levels unaffected 
 
We measured the ER [Ca2+] ([Ca2+]er) in HeLa cells transfected with ER-targeted 
aequorin . In these experiments, the ER Ca2+ store was first depleted of Ca2+, during the 
phase of aequorin reconstitution, performed in Ca2+-free medium (as described in 
Materials and methods, section 6). When Ca2+ was added back to the KRB perfusion 
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medium, [Ca2+]er rose from <10 µM to a plateau value of ~400 µM. No significant difference 
was observed between m/p-AKT1 overexpressing and control cells (348 ± 20.08 µM and 
357.16 ± 19.68 µM, n = 21; p > 0.1) (Fig. 31 A). 
We then investigated the ER response to histamine, which acts on Gq-coupled 
plasma membrane receptors and causes the production of IP3, thus releasing Ca2+ from 
the ER through the IP3Rs, followed by sustained influx from the extracellular medium 
through plasma membrane Ca2+ channels (Fig. 31 B). When the [Ca2+] in the lumen of the 
ER reached a plateau value, the cells were treated with histamine. As expected, a 
decreases in the [Ca2+] of the ER compartment was observed both in control and m/p-
AKT1 expressing cells (Fig. 31 B), but the decrease of [Ca2+] in control cells was extremely 
larger and faster (Vmax: 23.03 ± 2.02 µM/sec. vs 3.87 ± 0.5 µM/sec.; mean of first 50 sec. of 
Ca2+ released: 3.67 ± 0.2 µM/sec. vs 1.56 ± 0.1 µM/sec., n = 21), thus reflecting a more 
rapid flow through the IP3-gated channels, in controls compared to m/p-AKT1 expressing 
cells. Then we investigated if m/p-AKT1 overexpression could affect the IP3Rs expression 
level: as shown in Fig. 31 C this was not the case. Indeed, both type 1 and type 3 IP3R, are 
expressed at comparable levels in m/p-AKT1 transfected and control cells. We are unable 
to detect the type 2 IP3R in HeLa cells, in according with previous reports showing that the 
amount of IP3R II in HeLa cells is very low compared with other subtypes [149, 150]. 
Thus, we conclude that m/p-AKT1 is able to inhibit agonist-induced ER Ca2+ release 
into the cytoplasm. 
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Fig. 31: Modifications of ER Ca2+ kinetic releases by overexpression of Akt in HeLa cells. (A) Effects of 
m/p-AKT1 on the ER Ca2+ concentration in control and in m/p-AKT1-overexpressing HeLa cells. (B) Reduced 
ER Ca2+ release in m/p-AKT1-overexpressing cells when stimulated with 100 µM histamine. To induce Ca2+ 
release from ER, the cells were challenged with an agonist that, trough interaction with G protein coupled 
receptors, evokes a rapid discharge from IP3Rs. The bars in the graph show the extent of the reduction in the 
mean rate of Ca2+ released induced by overexpressing m/p-AKT1 after cell stimulation, both for the first 50 
sec. (upper graph) and for the maximum rate (lower graph). (C) HeLa cells were transfected with m/p-AKT1 
or mock transfected in control cells. Western blot analysis shows that overexpression of constitutively active 
Akt does not affect the expression of different types of IP3 receptors. 
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5.2.2 Cytosolic and mitochondrial Ca2+ response to agonist stimulation is strongly impaired 
in m/p-AKT1 expressing cells 
 
The effect of m/p-AKT1 expression on the cytosolic Ca2+ signal elicited by agonist 
stimulation was investigated using cytosolic aequorin. Both in control and m/p-AKT1-
transfected cells, histamine stimulation causes a rapid rise in cytoplasmic  [Ca2+]cyt, 
followed by a gradually declining sustained plateau. In m/p-AKT1-transfected cells, the 
[Ca2+]cyt increases evoked by stimulation with histamine are significantly smaller than in 
controls (peak amplitude 1.07 ± 0.03 vs 2.72 ± 0.04 µM; n = 14) (Fig. 32 A). Then we 
evaluated whether m/p-AKT1 could affect Ca2+ handling in mitochondria, an important site 
for decoding cellular Ca2+ signals and in particular Ca2+ signals regulating apoptosis. Both 
in control and m/p-AKT1-transfected cells, histamine stimulation caused a large, rapid rise 
in [Ca2+]mt, that returned to almost basal levels in approx 1 min. However, in m/p-AKT1-
transfected cells, the [Ca2+]mt increases evoked by stimulation with histamine were 
drastically smaller than in controls (peak amplitude 76.82 ± 3.4 µM control, 22.84 ± 2.2 µM 
m/p-AKT1, n = 18) (Fig. 32 B). 
Taken together, these data show that m/p-AKT1 globally affects cellular Ca2+ 
signaling probably acting on the ER Ca2+ release machinery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: Alteration of cytosolic and mitochondrial Ca2+ homeostasis in Akt-overexpressing cells. (A) 
Cytosolic Ca2+ homeostasis in control and m/p-AKT1-overexpressing HeLa cells. (B) Mitochondrial Ca2+ 
homeostasis in control and m/p-AKT1-overexpressing HeLa cells. Where indicated, the cells were stimulated 
with 100 µM histamine. 
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5.2.3 Akt overexpression protects against Ca2+-mediated cell death 
 
Mitochondrial Ca2+ uptake has been shown to be a fundamental factor in the 
activation of the intrinsic apoptotic pathway and in sensitizing the response to several 
apoptotic stimuli [33, 36, 151]. Reduction of mitochondrial Ca2+ accumulation by m/p-AKT1 
thus might result in diminished cellular sensitivity to Ca2+-mediated apoptosis. Therefore, 
we applied oxidative stress and arachidonic acid to induce apoptosis in HeLa cells, as they 
act through mitochondrial Ca2+ overload and ensuing activation of the intrinsic apoptotic 
pathway. HeLa cells were transiently transfected with mitochondrially targeted GFP alone 
(control) or in combination with m/p-AKT1 (m/p-AKT1), and 36 h after transfection the cells 
were treated with (1 mM) H2O2 or (80 µM) arachidonic acid. After 3 h incubation with the 
apoptotic stimulus of interest, and elimination of dead cells we observed a substantial 
increase in the proportion of m/p-AKT1-expressing cells after treatment (H2O2: 25.4 ± 
5.11% increase in m/p-AKT1/mtGFP-overexpressing cells, n = 11; arachidonic acid: 19.67 
± 6.04% increase in m/p-AKT1/ mtGFP-overexpressing cells, n = 9. p < 0.05) (Fig. 33 A). 
In this experimental setup positive changes in the percentage of surviving transfected cells 
indicates protection against the apoptotic stimulus by the overexpressed protein, while 
reduction provides evidence for its proapoptotic effect, thus Akt protected a significant 
number of cells from H2O2 and arachidonic acid. 
These data were confirmed by the direct measurement of caspase activity in H2O2 
and arachidonic acid treated cells, showing a marked reduction of caspase-3 activity in 
m/p-AKT1 overexpressing cells (Fig. 33 B). 
These results provided evidence that the m/p-AKT1-induced reduction of ER Ca2+ 
release increases the threshold for Ca2+-mediated apoptosis. 
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Fig. 33: Effect of Akt on cell death induced by Ca2+-dependent apoptotic stimuli. (A) HeLa cells were 
co-transfected with mtGFP and m/p-AKT1 or mtGFP alone in control cells. At 36 h post-transfection, cells 
were treated with arachidonic acid (80 µM) and H2O2 (1 mM) for 4 h. The data show the change of 
percentage of GFP fluorescent cells among the whole cell population (determined by phase contrast 
microscopy), averaging values obtained by analyzing more than 50 fields. (B) HeLa cells were transfected 
and treated at the same manner of (A), and then aliquots of cells were centrifuged and lysates were assayed 
for caspase-3 activity as described in section 6. The left panel shows representative traces of a singular 
experiment. The data are the mean of different angular coefficients ± SE. of 5 independent experiments; the 
bars in the graph (right panel) show the change of percentage of caspase-3 activation compared to untreated 
cells. 
 
5.2.4 Akt inhibits [Ca2+]cyt increases induced by H2O2 and arachidonic acid 
 
Apoptosis induced by H2O2 and arachidonic acid is triggered, or enhanced, by the 
release of Ca2+ from ER [152, 153]. Thus, we investigated whether m/p-AKT1, acting on 
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IP3Rs, had a direct effect on cytosolic apoptotic Ca2+ signals triggered by these apoptotic 
stimuli. 
Given that aequorin is not accurate enough to reveal small increases of [Ca2+], i.e. 
those expected in the cytosol after apoptotic stimulation, the [Ca2+]cyt was measured with 
the fluorescent indicator Fura-2/AM [154]. In these experiments, in order to identify m/p-
AKT1-overexpressing cells in single cell imaging experiments, the cells were co-
transfected with mtGFP [57]. GFP-positive cells were distinguished from controls by the 
typical fluorescence emitted upon illumination with blue light. As shown in Fig. 33, 
treatment with 1 mM H2O2 (Fig. 34 A) or 80 µM arachidonic acid (Fig. 34 B) caused a 
[Ca2+]cyt elevation, that gradually increased with time (Fig. 34). The simplest explanation for 
these results is that, as well as in the case of ceramide treatment, also these apoptotic 
stimuli caused a progressive release of Ca2+ from intracellular stores, thereby directly 
causing a [Ca2+]cyt rise and activating capacitative Ca2+ influx, that in turn is responsible for 
maintaining a long lasting [Ca2+]cyt plateau. Interestingly, in m/p-AKT1-transfected cells, the 
[Ca2+]cyt increases evoked by stimulation with H2O2 and arachidonic acid were significantly 
smaller than in controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34: Akt reduces [Ca2+]cyt elevation generated by H2O2 and arachidonic acid. Effects of m/p-AKT1 on 
[Ca2+]cyt increase induced by H2O2 (A) and Ar. Ac. (B). HeLa cells were loaded with the Ca2+ indicator Fura-
2/AM and [Ca2+]cyt changes were measured as details in section 6. The coverslips with the cells were 
maintained in 1 mM Ca2+/KRB and, where indicated, the cells were challenged with 1mM H2O2 or 80 µM 
arachidonic acid. The traces show the calibrated [Ca2+]cyt values. Experiments were repeated at least 5 times. 
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5.3 Discussion 
 
Virtually in all eukaryotic cells the dynamic regulation of [Ca2+]cyt is fundamental for 
cell life [1, 147]. In distinction to the other messengers, several organelles diffused 
throughout the cell can sequester Ca2+ and, in response to appropriate signals, release it 
back into the cytoplasm. Intracellular Ca2+ stores play an essential role in completing this 
regulation. The most important intracellular Ca2+ store is represented by the ER in non-
muscle cells, and by its specialized counterpart, the sarcoplasmic reticulum, in muscle 
cells [40]. The Ca2+ channels responsible for the rapid release of Ca2+ from the ER in 
response to extracellular stimuli are the families of IP3Rs [144]. Coordinated activation of 
these receptors is responsible for the generation of elementary and global (oscillating or 
persistent) Ca2+ signals observed in the cytosol [77, 155, 156]. 
Strong evidence has been also accumulated supporting a central role of Ca2+ in the 
regulation of cell death [120]. Recently it has been recognized, that modification of the ER 
Ca2+ pool may itself be involved in the initiation and regulation of the apoptotic process. As 
to ER Ca2+ release, it has been shown that owing to the efficient Ca2+ signal transmission 
between ER and mitochondria, ER Ca2+ release via IP3R play a pivotal role in transmitting 
apoptotic Ca2+ signals into mitochondria [157, 158] and can sensitize to ceramide induced 
apoptosis [34, 151]. The involvement of IP3Rs in sensitisation to apoptotic stimuli has been 
shown also by transgenic and anti-sense techniques. Thus, IP3R-deficient lymphocytes are 
resistant to a large panel of apoptosis inducers [159] and anti-sense oligonucleotide-
mediated downregulation of IP3R decreases the cell death of glucocorticoid-treated T cells 
[160] and NGF-depleted neurons [157]. Akt has been found associated to ER membranes 
[161] and IP3Rs can be phosphorylated by the well known apoptotic inhibitor Akt kinase 
[143]. 
The data presented here show that overexpression of m/p-AKT1 did not change the 
steady-state [Ca2+]er level. In contrast, after stimulation with histamine we observed a 
dramatic reduction in the speed of Ca2+ release, without any changes of the IP3R 
expression levels. Thus we can conclude that Akt was regulating IP3R activity. This 
modulation of IP3R activity resulted in an inhibition of agonist-induced Ca2+ release as we 
can observed measuring the cytosolic and mitochondrial Ca2+ responses. 
More interestingly for an antiapoptotic protein such as Akt, its overexpression 
significantly blunted the [Ca2+]cyt increases induced by H2O2 and arachidonic acid. This 
apoptotic protocol was chosen because shown to act through Ca2+ and, in our hands, Akt 
was highly efficient in protecting cells from death induced by these stimuli. 
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At this stage we can not ascribe the alterations of ER Ca2+ release to a direct Akt-
dependent phosphorylation of the IP3R. Indeed, in a recent work, Joseph and colleagues 
reported as the Ca2+ flux properties of IP3R mutants in their Akt substrate motif did not 
reveal any modification of channel function under agonist stimulation [143]. A possibility is 
that m/p-AKT1 phosphorylates other proteins interacting with the IP3Rs and in turn the 
phosphorylation state of these proteins regulates the IP3-mediated Ca2+ channel activity of 
IP3Rs. However, and probably more interestingly for a pro-survival protein, the Akt-
dependent IP3R phosphorylation appears functional to suppress the activation of cell death 
program triggered by apoptotic stimuli [143]. In agreement with this observation, our data 
clearly demonstrated that the overexpression of m/p-AKT1 chimera is efficient in reducing 
significantly the apoptotic Ca2+ signals induced by H2O2 and arachidonic acid. 
Thus, these observations may provide one mechanism of Akt to restrain the apoptotic 
effects of Ca2+ (Fig. 35). 
Fig. 35: Schematic model of Akt ability to protect cells from apoptosis through inhibition of Ca2+ 
release from IP3R. 
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6. Materials and methods 
 
6.1 Cell culture, infection and transfection 
 
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), in 75-cm2 Falcon flasks. For the 
aequorin experiments, the cells were seeded onto 13-mm glass coverslips and allowed to 
grow to 75% confluence. At this stage, transfection with 4 µg of total DNA (3 µg of 
indicated expression plasmids + 1 µg of AEQ) was carried out as previously described [63]. 
In order to measure [ATP]mt (Fig. 23), we worked similarly to aequorin  experiments, 
using 4 µg of total DNA (3 µg of Fhit + 1 µg of mtLUC). 
For experiments with Fura-2A/M (Fig. 23, 33), TMRM (Fig. 22), mitochondrial 
structure (Fig. 22) and apoptotic counts (Fig. 25, 32), cells were seeded on 24 mm 
coverslips and co-transfected 1:1 ratio with plasmid of interest and mtGFP, for a total 
amount of 8 µg of DNA. 
For experiments with mtRP probe (Fig. 23 B), cells were seeded on 24 mm coverslips 
and co-transfected 3:1 (control: 6 µg empty vector + 2 µg mtRP; Fhit: 6 µg Fhit + 2 µg 
mtRP) 
For Fhit shRNA silencing in HeLa cells, lentiviral (shRNA Fhit: shRNAFhit-pLKO.1) 
vectors were used, in association with adenoviral vectors for the expression of the 
aequorin probes (mtAEQ-pAdEasy). 
All measurements were performed 36 h after transfection. 
 
MEFs derived from wild-type p66Shc -/- and Pin1 -/- mice were grown in Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 10% fetal bovine serum (FBS), in 
75cm2 Falcon flasks. For aequorin measurements, the cells were seeded before 
transfection onto 13 mm glass coverslips and allowed to grow to 50% confluence. At this 
stage, the cells were infected with the adenovirus expressing the appropriate chimera, as 
previously described [162]. For analyzing mitochondrial structure and PKC β translocation, 
the cells (seeded onto 24 mm coverslips) were transfected with mtGFP using lipofectamine 
(Invitrogen) or infected with an adenoviral vector driving PKCβ-GFP expression. 
Pin1 over-expression in MEFs wt was performed with lipofectamine (Invitrogen). 
For retrieval infections, we used a PINCO vector expressing the p66Shc moiety of 
interest and GFP from an internal CMV promoter. MEFs derived from p66Shc- /- mice 
were infected with vector alone, p66Shc wt, the non-phosphorylatable mutant p66ShcS36A 
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or the p66ShcE132Q-E133Q mutant (p66Shcqq), incapable of binding cytochrome c, as 
described previously [71, 76]. 
The efficiency of infection (90%) was determined by FACS analysis of GFP positive 
cells 48 h after infection. 
 
A549 cells were maintained in RPMI-1640 medium plus 10% FBS. 
For Fhit overexpression in A549, adenoviral (AdFhit: Fhit-His-6pAdenoVator-CMV5-
IRESGFP, AdmtGFP: mtGFP-pAdEasy) vectors were used, in association with adenoviral 
vectors for the expression of the aequorin probes (AdmtAEQ). 
 
 
6.2 Construction of mtFhit chimera 
 
For constructing mtFhit, an in frame HindIII site and the HA1 tag were added via 
suitable PCR primers, then the HA-Fhit coding sequence was ligated to the mitochondrial 
targeting sequence (derived from subunit VIII of COX) excised from mtAEQ [45]. The final 
construct was cloned into the pcDNA3.1 expression vector. 
 
 
6.3 Aequorin measurements 
 
For cytAEQ and mtAEQ 24 hours after transfection, transfected aequorin was 
reconstituted by incubating the cells for 1 to 3h with 5 µM coelenterazine in DMEM 
supplemented with 1% fetal calf serum in a 5% CO2 atmosphere.  
For erAEQ, before the reconstitution it is necessary to drastically reduce the Ca2+ 
content of the endoplasmic reticulum.  To this end, the cells were incubated for 1 h at 4 C 
(in order to preserve membranes integrity), in KRB (Krebs-Ringer modified buffer: 125 mM 
NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES, pH 7.4, 
37C) supplemented with coelenterazine 5 µM, the Ca2+ ionophore ionomycin (5 µM) and 
600µM EGTA. After this incubation the cells were extensively washed with KRB 
supplemented with 2% BSA (bovine serum albumin) and 1mM EGTA. During the 
experiments, the cells were perfused with modified Krebs-Ringer buffer (KRB) (125 mM 
NaCl, 5 mM KCl, 1mM Na3PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES, pH 7.4 at 
37°C), supplemented with 1 mM CaCl2 (KRB/Ca2+) and challenged with agonists and drugs 
added to the same medium.  
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In the experiments with permeabilized cells, a buffer mimicking the cytosolic ionic 
composition, (“intracellular buffer”, IB) was employed: 140 mM KCl, 10 mM NaCl, 1 mM 
K3PO4, 5.5 mM glucose, 2 mM MgSO4, 1 mM ATP, 2 mM sodium succinate, 20 mM Hepes 
(pH 7.05 at 37C). The experiments were terminated by lysing the cells with 100µM digitonin 
in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O), thus discharging the remaining 
aequorin pool. After transfer to the luminometer chamber, Ca2+ uptake into mitochondria 
was initiated by replacing IB/EGTA with IB containing a 2 mM EGTA-buffered [Ca2+] of 1 
µM, prepared as elsewhere described [163]. The light signal was collected and calibrated 
into [Ca2+]  values as previously described [46, 48, 63].  
In brief, a 13 mm-round coverslip with the transfected cells was placed in a perfused, 
thermostatted chamber, placed in the close proximity of a low-noise photomultiplier, with 
built-in amplifier-discriminetor. The output of the discriminator was captured by a Thorn-EMI 
photon counting board and stored in an IBM-compatible computer for further analyses. The 
aequorin luminescence data werte calibrated off-line into [Ca2+] values, using a computer 
algorithm based on the Ca2+ response curve of wild-type and mutant aequorins, as 
previously described [46, 48]. 
 
 
6.4 Luciferase measurements 
 
Cell luminescence was measured in the same purpose-built luminometer used for the 
aequorin measurements. Cells were constantly perfused with KRB, supplemented with 1 
mM CaCl2 and 20 µM luciferin. All additions were made to this medium, as specified in the 
figure legend. The light output of a coverslip of transient trasfected cells was in the range of 
1,000 - 10,000 counts per second (cps) versus a background lower than 10 cps. All 
compounds employed in the experiments were tested for non-specific effects on the 
luminescence and none were observed.  
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6.5 Fura-2/AM measurements 
 
Cytosolic free Ca2+ concentration was evaluated using fluorescent Ca2+ indicator 
Fura-2/AM (Molecular Probes, Inc.). Briefly, cells were incubated in medium supplemented 
with 2.5 µM Fura-2/AM for 30 min, washed with KRB to remove extracellular probe, 
supplied with preheated KRB (supplemented with 1 mM CaCl2), and placed in a 
thermostated incubation chamber at 37 °C on the stage of an inverted fluorescence 
microscope (Zeiss Axiovert 200). Dynamic video imaging was performed using MetaFluor 
software (Universal Imaging Corp.). Fluorescence was measured every 100 ms with the 
excitation wavelength alternating between 340 and 380 nm and the emission fluorescence 
being recorded at 510 nm. At the end of the experiment, a region free of cells was selected, 
and one averaged background frame was collected at each excitation wavelength for 
background correction. The [Ca2+]c was calculated by the ratio method using the equation: 
[Ca2+]c = Kd (R – Rmin) / (R – Rmax) x Sf2 / Sf1 where Kd is dissociation constant of Fura-
2/AM for (Ca2+) taken as 240 nM at 37 °C, R is ratio of fluorescence for Fura-2/AM at the 
two excitation wavelengths, F340/F380, Rmax is ratio of fluorescence in the presence of 
excess of calcium obtained by lysing the cells with 10 µM ionomycin (Sigma Aldrich), Rmin 
is ratio of fluorescence in the presence of minimal calcium obtained by lysing the cells and 
then chelating all the Ca2+ with 0.5 M EGTA, Sf2 is fluorescence of Ca2+ free form of Fura-
2/AM at 380nm excitation wavelength and Sf1 is fluorescence of Ca2+ bound form of Fura-
2/AM at 380 nm excitation wavelength. 
 
 
6.6 Caspase 3 assay 
 
Cells were centrifuged (1000 g for 5 min.) and washed once in phosphate-buffered 
saline. The enzcheck® caspase-3 assay kit # 2 by Molecular Probes was used for 
determination of caspase-3 activity. Lysate (20 µg), resuspended in a final volume of 100 
µl, was assayed using Wallac 1420 Victor 3 multitask plate reader (Perkin Elmer, Inc.). 
 
 
6.7 Apoptotic counts 
 
The mtGFP fluorescent marker was coexpressed with plasmid of interest, and effect 
on cell survival was estimated by calculating the fraction of fluorescent cells in the 
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surviving population after an apoptotic challenge. Ten different fields per coverslip (taken 
with an objective 20 X) were analyzed, and a mean per condition was extracted. 
The results were obtained from at least 3 coverslips per condition and expressed as 
variation in the percentage of fluorescent cells. 
 
 
6.8 Annexin V assay 
 
After treatment with apoptotic stimulus, control cells or cells overexpressing the 
protein of interest, were incubated with the Alexa Fluor 488 Annexin V antibody kit, 
according to the instruction of the producer (Molecular Probes), and then sorted with a 
FACStar flow cytometer (Becton Dickinson). 
 
 
6.9 Cell cycle analysis 
 
For cell cycle analyses, control or transfected cells were washed twice with cold 
ethanol, then resuspended in 0.1 mg/mL propidium iodide/Triton X-100 staining solution 
(0.1% Triton X-100, 20 mg/ml DNase-free RNase A), and analyzed by flow cytometry, as 
described above. 
 
 
6.10 Microscopic analysis of mitochondrial structure and PKC β translocation 
 
Images of mitochondrial structure and PKC translocation were obtained by visualizing 
mtGFP or PKC β-GFP chimera, using a digital imaging system based on a Zeiss Axiovert 
200 fluorescence microscope equipped with a back-illuminated CCD camera (Roper 
Scientific, USA), excitation and emission filterwheels (Sutter Instrument Company, USA) 
and piezoelectric motoring of the z stage (Physik Instrumente, GmbH & Co., Germany). 
The data were acquired and processed using the MetaMorph analysis program (Universal 
Imaging Corporation, USA). For computational deblurring, a stack of images through the z 
plane was acquired (200 ms/image; 20 plans 0.5 µm apart) and processed using the EPR 
software developed by the Biomedical Imaging Group of the University of Massachusetts 
Medical School (Worcester, MA, USA) [66]. 
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6.11 Mitochondrial membrane potential measurements 
 
Mitochondrial membrane potential (∆Ψm) was measured using 10 nM tetramethyl 
rhodamine methyl ester (TMRM) on a confocal microscope (model LSM 510; Carl Zeiss 
MicroImaging, Inc.). FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), to 
collapses mitochondrial ∆Ψ. The signal was collected as total emission >570 nm. 
 
 
6.12 mtRP measurements 
 
Mitochondrial Hot Spots was measured used mtRP probe (transfected as indicated in 
section 6.1) on a digital imaging system based on a Zeiss Axiovert 200 fluorescence 
microscope. Excitation λ is at 410/490 nm. Specifically, for the images of Fig. 24 B, the first 
deconvoluted image in the series was used as threshold to create a binary mask, allowing 
visualization of only the mitochondrial network. ∆F/F images were calculated from the 
original images and were multiplied by the binary mask with the image arithmetic functions 
of the MetaMorph software. Image scaling and pseudocolors were applied with the 
MetaFluor Analyst software of the Meta Imaging software package. 
 
 
6.13 Immunofluorescence 
 
Cells were fixed with 4% formaldehyde for 10 min at RT. After washing twice with 
phosphate-buffered saline (PBS), cells were permeabilized with 0.2% Triton X-100 in PBS 
(PBST) at RT for 10 min and treated with PBST containing 5% skim milk (PBSTM) at RT 
for 1 h. Cells were incubated with a monoclonal antibody to Fhit (Zymed Laboratories, 1 
µg/ml, Fig. 21) or with monoclonal antibody to HA1 (Santa Cruz Biotechnology, 5 µg/ml, 
Fig. 25) in PBSTM overnight at 4 °C, washed three times with PBS, and then incubated 
with Alexa-546-conjugated anti-rabbit IgG (Molecular Probes) at RT for 1 h. After washing 
five times with PBS, slides were mounted in Vectashield (Vector Laboratories). Fluorescent 
images were taken through an inverted microscope with a 63 X Carl Zeiss objective. 
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6.14 Isolation of mitochondria 
 
Cells were washed twice with PBS, resuspended and homogenized in a buffer 
containing 250 mM sucrose, 1 mM EGTA, 50 mM Tris-HCl, 1mM DTT, protease inhibitor 
cocktail, pH 7.4 with 40 µg of digitonin per ml in a glass homogenizer. Homogenate was 
centrifuged at 1,500 x g for 5 min twice. The final supernatant was collected and 
centrifuged at 10,000 x g for 10 min, the mitochondrial pellets were resuspended with 
homogenization buffer (without digitonin) and centrifuged again at 10,000 x g for 10 min. 
Mitochondrial pellets were disrupted in 100 µl lysis buffer at 4 °C, incubated 30 min. on ice 
and then centrifuged at 17,000 x g for 30 min. Protein concentration in the supernatant was 
determined by the Bio-Rad protein estimation kit. 
 
 
6.15 In vitro binding (Fig.19 A) 
 
In GST-pull-down assays ΦNX cells overexpressing p66Shc cDNA and p66ShcS36A 
mutant non irradiated or UVc-irradiated (50 J/m2 for 10 min), were lysed in JS buffer (20 
mMTris-HCl pH 7.8, 50 mM NaF, 50 mM NaCl, 30 mM Na4P2O7, 1% Triton X-100) 
containing freshly added protease inhibitors (1 mM phenylmethylsulfonylfluoride, 10 µg/ml 
leupeptin and 5 mg/ml aprotinin). Lysates were clarified by centrifugation at 4 °C and 
incubated (1 mg) with 10 µl of agarose beads containing GST-Pin1 proteins or control GST 
for 2 hours at 4 °C. In the case of phosphatase treatment, 20 U/ml of CIP (New England 
Biolabs) were added to the lysates and the reaction was continued for 30 min. at 30 °C. 
The precipitated proteins were washed five times in the same buffer and subjected to 
immunoblotting analysis with anti-Shc antibodies. 
 
 
6.16 Immunoprecipitation (Fig. 16 C) 
 
MEFs maintained in growth conditions (10% FCS) after 24 hours pre-incubation with 
5 µM hispidin (where indicated) were challenged for 10 min with 500 µM H2O2 or 100 ng/ml 
TPA. Cellular extracts were lysed in JS buffer (20 mM Tris-HCl ph 7.8, 50 mM NaF, 50 mM 
NaCl, 30 mM Na4P2O7, 5 mM Sodium Orthovanadate, 1% Triton X-100) containing 
protease inhibitors (PMSF, leupeptin and aprotinin), immunoprecipitated with polyclonal 
anti-Shc antibodies (Transduction Laboratories), and analyzed by immunoblotting with a 
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specific monoclonal antiphospho-(Ser36) p66Shc antibodies (Alexis) or with anti-Shc 
antibodies (Tansduction Laboratories). 
 
 
6.17 Immunoblot 
 
Lysates were centrifuged at 11,000 × g for 20 min, and then the supernatants were 
collected and conserved at -80 °C. The proteins (5-30 µg) were separated on 7-12% 
polyacrylamide gel and transferred to Nitrocellulose membrane. 
Different antibodies used in this thesis are: 
 PKCβ (BD Biosciences), dilution 1:500 
 (αSH2)p66Shc (Santa Cruz Biotechnology), dilution 1:500 
 αpS36p66Shc (Calbiochem), dilution 1:1000 
 Actin (Cell Signalling), dilution 1:1000 
 VDAC (Cell Signalling), dilution 1:1000 
 Fhit (Zymed Laboratories), dilution 1:5000 
 β-tubulin (Santa Cruz Biotechnology), dilution 1:1000 
 IP3R I (Santa Cruz Biotechnology), dilution 1:200 
 IP3R III (BD Biosciences), dilution 1:1000 
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